id	sid	tid	token	lemma	pos
gra-59	1	1	breast	breast	NOUN
gra-59	1	2	is	be	AUX
gra-59	1	3	the	the	DET
gra-59	1	4	most	most	ADV
gra-59	1	5	common	common	ADJ
gra-59	1	6	site	site	NOUN
gra-59	1	7	of	of	ADP
gra-59	1	8	cancer	cancer	NOUN
gra-59	1	9	in	in	ADP
gra-59	1	10	women.breast	women.breast	NOUN
gra-59	1	11	cancer	cancer	NOUN
gra-59	1	12	is	be	AUX
gra-59	1	13	a	a	DET
gra-59	1	14	disease	disease	NOUN
gra-59	1	15	in	in	ADP
gra-59	1	16	which	which	PRON
gra-59	1	17	breast	breast	NOUN
gra-59	1	18	cells	cell	NOUN
gra-59	1	19	proliferate	proliferate	VERB
gra-59	1	20	abnormally	abnormally	ADV
gra-59	1	21	and	and	CCONJ
gra-59	1	22	may	may	AUX
gra-59	1	23	present	present	VERB
gra-59	1	24	as	as	ADP
gra-59	1	25	a	a	DET
gra-59	1	26	breast	breast	NOUN
gra-59	1	27	lump	lump	NOUN
gra-59	1	28	,	,	PUNCT
gra-59	1	29	thickening	thickening	NOUN
gra-59	1	30	,	,	PUNCT
gra-59	1	31	or	or	CCONJ
gra-59	1	32	skin	skin	NOUN
gra-59	1	33	change	change	NOUN
gra-59	1	34	.	.	PUNCT
gra-59	2	1	when	when	SCONJ
gra-59	2	2	breast	breast	NOUN
gra-59	2	3	cancer	cancer	NOUN
gra-59	2	4	cells	cell	NOUN
gra-59	2	5	metastasize	metastasize	VERB
gra-59	2	6	from	from	ADP
gra-59	2	7	the	the	DET
gra-59	2	8	original	original	ADJ
gra-59	2	9	tumor	tumor	NOUN
gra-59	2	10	and	and	CCONJ
gra-59	2	11	enter	enter	VERB
gra-59	2	12	the	the	DET
gra-59	2	13	blood	blood	NOUN
gra-59	2	14	stream	stream	NOUN
gra-59	2	15	or	or	CCONJ
gra-59	2	16	lymphatic	lymphatic	ADJ
gra-59	2	17	system	system	NOUN
gra-59	2	18	,	,	PUNCT
gra-59	2	19	they	they	PRON
gra-59	2	20	can	can	AUX
gra-59	2	21	form	form	VERB
gra-59	2	22	secondary	secondary	ADJ
gra-59	2	23	tumors	tumor	NOUN
gra-59	2	24	,	,	PUNCT
gra-59	2	25	locate	locate	VERB
gra-59	2	26	in	in	ADP
gra-59	2	27	other	other	ADJ
gra-59	2	28	parts	part	NOUN
gra-59	2	29	of	of	ADP
gra-59	2	30	the	the	DET
gra-59	2	31	body	body	NOUN
gra-59	2	32	.	.	PUNCT
gra-59	3	1	a	a	DET
gra-59	3	2	biopsy	biopsy	NOUN
gra-59	3	3	is	be	AUX
gra-59	3	4	necessary	necessary	ADJ
gra-59	3	5	to	to	ADP
gra-59	3	6	conrm	conrm	VERB
gra-59	3	7	the	the	DET
gra-59	3	8	diagnosis	diagnosis	NOUN
gra-59	3	9	and	and	CCONJ
gra-59	3	10	determine	determine	VERB
gra-59	3	11	the	the	DET
gra-59	3	12	type	type	NOUN
gra-59	3	13	of	of	ADP
gra-59	3	14	cancer	cancer	NOUN
gra-59	3	15	present	present	ADJ
gra-59	3	16	.	.	PUNCT
gra-59	4	1	the	the	DET
gra-59	4	2	incidence	incidence	NOUN
gra-59	4	3	of	of	ADP
gra-59	4	4	breast	breast	NOUN
gra-59	4	5	cancer	cancer	NOUN
gra-59	4	6	increases	increase	NOUN
gra-59	4	7	with	with	ADP
gra-59	4	8	age	age	NOUN
gra-59	4	9	,	,	PUNCT
gra-59	4	10	being	be	AUX
gra-59	4	11	uncommon	uncommon	ADJ
gra-59	4	12	below	below	ADP
gra-59	4	13	the	the	DET
gra-59	4	14	age	age	NOUN
gra-59	4	15	of	of	ADP
gra-59	4	16	32	32	NUM
gra-59	4	17	years	year	NOUN
gra-59	4	18	;	;	PUNCT
gra-59	4	19	however	however	ADV
gra-59	4	20	its	its	PRON
gra-59	4	21	behaviour	behaviour	NOUN
gra-59	4	22	varies	vary	VERB
gra-59	4	23	from	from	ADP
gra-59	4	24	slow	slow	ADJ
gra-59	4	25	to	to	PART
gra-59	4	26	rapid	rapid	ADJ
gra-59	4	27	progressive	progressive	ADJ
gra-59	4	28	disease	disease	NOUN
gra-59	4	29	despite	despite	SCONJ
gra-59	4	30	available	available	ADJ
gra-59	4	31	treatment	treatment	NOUN
gra-59	4	32	.	.	PUNCT
gra-59	5	1	carcinoma	carcinoma	NOUN
gra-59	5	2	of	of	ADP
gra-59	5	3	the	the	DET
gra-59	5	4	breast	breast	NOUN
gra-59	5	5	is	be	AUX
gra-59	5	6	the	the	DET
gra-59	5	7	second	second	ADJ
gra-59	5	8	commonest	commonest	NOUN
gra-59	5	9	malignancy	malignancy	NOUN
gra-59	5	10	affecting	affect	VERB
gra-59	5	11	half	half	DET
gra-59	5	12	a	a	DET
gra-59	5	13	million	million	NUM
gra-59	5	14	women	woman	NOUN
gra-59	5	15	worldwide	worldwide	ADV
gra-59	5	16	each	each	DET
gra-59	5	17	year	year	NOUN
gra-59	5	18	.	.	PUNCT
gra-59	6	1	it	it	PRON
gra-59	6	2	is	be	AUX
gra-59	6	3	one	one	NUM
gra-59	6	4	of	of	ADP
gra-59	6	5	the	the	DET
gra-59	6	6	major	major	ADJ
gra-59	6	7	causes	cause	NOUN
gra-59	6	8	of	of	ADP
gra-59	6	9	death	death	NOUN
gra-59	6	10	among	among	ADP
gra-59	6	11	women	woman	NOUN
gra-59	6	12	between	between	ADP
gra-59	6	13	40	40	NUM
gra-59	6	14	and	and	CCONJ
gra-59	6	15	44	44	NUM
gra-59	6	16	years	year	NOUN
gra-59	6	17	age	age	NOUN
gra-59	6	18	group	group	NOUN
gra-59	6	19	that	that	PRON
gra-59	6	20	has	have	AUX
gra-59	6	21	become	become	VERB
gra-59	6	22	a	a	DET
gra-59	6	23	genuine	genuine	ADJ
gra-59	6	24	public	public	ADJ
gra-59	6	25	health	health	NOUN
gra-59	6	26	problem	problem	NOUN
gra-59	6	27	.	.	PUNCT
gra-59	7	1	epidemiological	epidemiological	ADJ
gra-59	7	2	studies	study	NOUN
gra-59	7	3	have	have	AUX
gra-59	7	4	revealed	reveal	VERB
gra-59	7	5	that	that	SCONJ
gra-59	7	6	1	1	NUM
gra-59	7	7	in	in	ADP
gra-59	7	8	50	50	NUM
gra-59	7	9	women	woman	NOUN
gra-59	7	10	in	in	ADP
gra-59	7	11	india	india	PROPN
gra-59	7	12	can	can	AUX
gra-59	7	13	develop	develop	VERB
gra-59	7	14	breast	breast	NOUN
gra-59	7	15	cancer	cancer	NOUN
gra-59	7	16	in	in	ADP
gra-59	7	17	their	their	PRON
gra-59	7	18	lifetime.1	lifetime.1	VERB
gra-59	7	19	according	accord	VERB
gra-59	7	20	to	to	ADP
gra-59	7	21	globocan	globocan	PROPN
gra-59	7	22	(	(	PUNCT
gra-59	7	23	who	who	PRON
gra-59	7	24	)	)	PUNCT
gra-59	7	25	,	,	PUNCT
gra-59	7	26	for	for	ADP
gra-59	7	27	the	the	DET
gra-59	7	28	year	year	NOUN
gra-59	7	29	2012	2012	NUM
gra-59	7	30	,	,	PUNCT
gra-59	7	31	an	an	DET
gra-59	7	32	estimated	estimate	VERB
gra-59	7	33	70218	70218	NUM
gra-59	7	34	women	woman	NOUN
gra-59	7	35	died	die	VERB
gra-59	7	36	in	in	ADP
gra-59	7	37	india	india	PROPN
gra-59	7	38	due	due	ADP
gra-59	7	39	to	to	ADP
gra-59	7	40	breast	breast	NOUN
gra-59	7	41	cancer	cancer	NOUN
gra-59	7	42	,	,	PUNCT
gra-59	7	43	more	more	ADJ
gra-59	7	44	than	than	ADP
gra-59	7	45	any	any	DET
gra-59	7	46	other	other	ADJ
gra-59	7	47	country	country	NOUN
gra-59	7	48	in	in	ADP
gra-59	7	49	the	the	DET
gra-59	7	50	world	world	NOUN
gra-59	7	51	(	(	PUNCT
gra-59	7	52	second	second	ADJ
gra-59	7	53	:	:	PUNCT
gra-59	7	54	china	china	PROPN
gra-59	7	55	47984	47984	NUM
gra-59	7	56	deaths	death	NOUN
gra-59	7	57	and	and	CCONJ
gra-59	7	58	third	third	ADV
gra-59	7	59	:	:	PUNCT
gra-59	7	60	us	us	PROPN
gra-59	7	61	43909	43909	NUM
gra-59	7	62	deaths	death	NOUN
gra-59	7	63	)	)	PUNCT
gra-59	7	64	.	.	PUNCT
gra-59	8	1	2	2	NUM
gra-59	8	2	the	the	DET
gra-59	8	3	etiology	etiology	NOUN
gra-59	8	4	of	of	ADP
gra-59	8	5	lipid	lipid	NOUN
gra-59	8	6	changes	change	NOUN
gra-59	8	7	associated	associate	VERB
gra-59	8	8	with	with	ADP
gra-59	8	9	breast	breast	NOUN
gra-59	8	10	cancer	cancer	NOUN
gra-59	8	11	is	be	AUX
gra-59	8	12	multifactorial	multifactorial	ADJ
gra-59	8	13	and	and	CCONJ
gra-59	8	14	relationship	relationship	NOUN
gra-59	8	15	of	of	ADP
gra-59	8	16	lipid	lipid	NOUN
gra-59	8	17	changes	change	NOUN
gra-59	8	18	to	to	ADP
gra-59	8	19	breast	breast	NOUN
gra-59	8	20	cancer	cancer	NOUN
gra-59	8	21	is	be	AUX
gra-59	8	22	still	still	ADV
gra-59	8	23	a	a	DET
gra-59	8	24	subject	subject	NOUN
gra-59	8	25	of	of	ADP
gra-59	8	26	controversy	controversy	NOUN
gra-59	8	27	.	.	PUNCT
gra-59	9	1	some	some	DET
gra-59	9	2	studies	study	NOUN
gra-59	9	3	have	have	AUX
gra-59	9	4	found	find	VERB
gra-59	9	5	that	that	PRON
gra-59	9	6	malignant	malignant	ADJ
gra-59	9	7	proliferation	proliferation	NOUN
gra-59	9	8	of	of	ADP
gra-59	9	9	breast	breast	NOUN
gra-59	9	10	tissue	tissue	NOUN
gra-59	9	11	in	in	ADP
gra-59	9	12	women	woman	NOUN
gra-59	9	13	is	be	AUX
gra-59	9	14	associated	associate	VERB
gra-59	9	15	with	with	ADP
gra-59	9	16	changes	change	NOUN
gra-59	9	17	in	in	ADP
gra-59	9	18	plasma	plasma	NOUN
gra-59	9	19	lipid	lipid	NOUN
gra-59	9	20	and	and	CCONJ
gra-59	9	21	lipoprotein	lipoprotein	ADJ
gra-59	9	22	levels	level	NOUN
gra-59	9	23	.	.	PUNCT
gra-59	10	1	a	a	DET
gra-59	10	2	number	number	NOUN
gra-59	10	3	of	of	ADP
gra-59	10	4	epidemiological	epidemiological	ADJ
gra-59	10	5	studies	study	NOUN
gra-59	10	6	have	have	AUX
gra-59	10	7	shown	show	VERB
gra-59	10	8	the	the	DET
gra-59	10	9	inc	inc	PROPN
gra-59	10	10	reased	rease	VERB
gra-59	11	1	r	r	NOUN
gra-59	11	2	i	i	PRON
gra-59	11	3	sk	sk	VERB
gra-59	11	4	o	o	PROPN
gra-59	11	5	f	f	PROPN
gra-59	11	6	dea	dea	PROPN
gra-59	11	7	th	th	X
gra-59	11	8	f	f	PROPN
gra-59	11	9	rom	rom	PROPN
gra-59	11	10	cancer	cancer	NOUN
gra-59	12	1	w	w	PROPN
gra-59	12	2	i	i	PRON
gra-59	12	3	th	th	PROPN
gra-59	12	4	hypo	hypo	PROPN
gra-59	12	5	cholesterolaemia	cholesterolaemia	PROPN
gra-59	12	6	,	,	PUNCT
gra-59	12	7	although	although	SCONJ
gra-59	12	8	several	several	ADJ
gra-59	12	9	studies	study	NOUN
gra-59	12	10	proposed	propose	VERB
gra-59	12	11	the	the	DET
gra-59	12	12	low	low	ADJ
gra-59	12	13	levels	level	NOUN
gra-59	12	14	of	of	ADP
gra-59	12	15	cholesterol	cholesterol	NOUN
gra-59	12	16	is	be	AUX
gra-59	12	17	a	a	DET
gra-59	12	18	predisposing	predispose	VERB
gra-59	12	19	factor	factor	NOUN
gra-59	12	20	for	for	ADP
gra-59	12	21	carcinogenesis3	carcinogenesis3	PROPN
gra-59	12	22	so	so	SCONJ
gra-59	12	23	the	the	DET
gra-59	12	24	present	present	ADJ
gra-59	12	25	study	study	NOUN
gra-59	12	26	was	be	AUX
gra-59	12	27	planned	plan	VERB
gra-59	12	28	to	to	PART
gra-59	12	29	investigate	investigate	VERB
gra-59	12	30	the	the	DET
gra-59	12	31	alteration	alteration	NOUN
gra-59	12	32	in	in	ADP
gra-59	12	33	the	the	DET
gra-59	12	34	lipid	lipid	ADJ
gra-59	12	35	proles	prole	NOUN
gra-59	12	36	of	of	ADP
gra-59	12	37	patients	patient	NOUN
gra-59	12	38	with	with	ADP
gra-59	12	39	carcinoma	carcinoma	NOUN
gra-59	12	40	of	of	ADP
gra-59	12	41	breast	breast	NOUN
gra-59	12	42	in	in	ADP
gra-59	12	43	comparison	comparison	NOUN
gra-59	12	44	with	with	ADP
gra-59	12	45	age	age	NOUN
gra-59	12	46	matched	match	VERB
gra-59	12	47	control	control	NOUN
gra-59	12	48	women	woman	NOUN
gra-59	12	49	.	.	PUNCT
gra-59	13	1	the	the	DET
gra-59	13	2	aim	aim	NOUN
gra-59	13	3	of	of	ADP
gra-59	13	4	this	this	DET
gra-59	13	5	study	study	NOUN
gra-59	13	6	,	,	PUNCT
gra-59	13	7	therefore	therefore	ADV
gra-59	13	8	,	,	PUNCT
gra-59	13	9	is	be	AUX
gra-59	13	10	to	to	ADP
gra-59	13	11	nd	nd	ADV
gra-59	13	12	out	out	ADP
gra-59	13	13	the	the	DET
gra-59	13	14	effect	effect	NOUN
gra-59	13	15	of	of	ADP
gra-59	13	16	lipids	lipid	NOUN
gra-59	13	17	on	on	ADP
gra-59	13	18	breast	breast	NOUN
gra-59	13	19	cancer	cancer	NOUN
gra-59	13	20	risk	risk	NOUN
gra-59	13	21	.	.	PUNCT
gra-59	14	1	and	and	CCONJ
gra-59	14	2	an	an	DET
gra-59	14	3	attempt	attempt	NOUN
gra-59	14	4	made	make	VERB
gra-59	14	5	to	to	PART
gra-59	14	6	investigate	investigate	VERB
gra-59	14	7	the	the	DET
gra-59	14	8	levels	level	NOUN
gra-59	14	9	of	of	ADP
gra-59	14	10	total	total	ADJ
gra-59	14	11	cholesterol	cholesterol	NOUN
gra-59	14	12	(	(	PUNCT
gra-59	14	13	tch	tch	NOUN
gra-59	14	14	)	)	PUNCT
gra-59	14	15	,	,	PUNCT
gra-59	14	16	triglycerides	triglyceride	NOUN
gra-59	14	17	(	(	PUNCT
gra-59	14	18	tg	tg	NOUN
gra-59	14	19	)	)	PUNCT
gra-59	14	20	,	,	PUNCT
gra-59	14	21	low	low	ADJ
gra-59	14	22	density	density	NOUN
gra-59	14	23	lipoproteins	lipoprotein	NOUN
gra-59	14	24	(	(	PUNCT
gra-59	14	25	ldl	ldl	NOUN
gra-59	14	26	)	)	PUNCT
gra-59	14	27	very	very	ADV
gra-59	14	28	low	low	ADJ
gra-59	14	29	density	density	NOUN
gra-59	14	30	lipoproteins	lipoprotein	NOUN
gra-59	14	31	(	(	PUNCT
gra-59	14	32	vldl	vldl	NOUN
gra-59	14	33	)	)	PUNCT
gra-59	14	34	,	,	PUNCT
gra-59	14	35	high	high	ADJ
gra-59	14	36	density	density	NOUN
gra-59	14	37	lipoproteins	lipoprotein	NOUN
gra-59	14	38	(	(	PUNCT
gra-59	14	39	hdl	hdl	NOUN
gra-59	14	40	)	)	PUNCT
gra-59	14	41	in	in	ADP
gra-59	14	42	breast	breast	NOUN
gra-59	14	43	cancer	cancer	NOUN
gra-59	14	44	patients	patient	NOUN
gra-59	14	45	.	.	PUNCT
gra-59	15	1	aim	aim	NOUN
gra-59	15	2	&	&	CCONJ
gra-59	15	3	objectives	objective	NOUN
gra-59	15	4	:	:	PUNCT
gra-59	15	5	ÿ	ÿ	PRON
gra-59	15	6	estimate	estimate	VERB
gra-59	15	7	the	the	DET
gra-59	15	8	serum	serum	NOUN
gra-59	15	9	lipid	lipid	NOUN
gra-59	15	10	prole	prole	PROPN
gra-59	15	11	in	in	ADP
gra-59	15	12	breast	breast	NOUN
gra-59	15	13	cancer	cancer	NOUN
gra-59	15	14	patients	patient	NOUN
gra-59	15	15	.	.	PUNCT
gra-59	16	1	ÿ	ÿ	PROPN
gra-59	16	2	compare	compare	VERB
gra-59	16	3	the	the	DET
gra-59	16	4	serum	serum	NOUN
gra-59	16	5	lipid	lipid	NOUN
gra-59	16	6	prole	prole	PROPN
gra-59	16	7	of	of	ADP
gra-59	16	8	patient	patient	ADJ
gra-59	16	9	group	group	NOUN
gra-59	16	10	with	with	ADP
gra-59	16	11	control	control	NOUN
gra-59	16	12	groups	group	NOUN
gra-59	16	13	.	.	PUNCT
gra-59	17	1	materials	material	NOUN
gra-59	17	2	&	&	CCONJ
gra-59	17	3	methods	method	NOUN
gra-59	17	4	:	:	PUNCT
gra-59	17	5	a	a	DET
gra-59	17	6	hospital	hospital	NOUN
gra-59	17	7	based	base	VERB
gra-59	17	8	case	case	NOUN
gra-59	17	9	-	-	PUNCT
gra-59	17	10	control	control	NOUN
gra-59	17	11	study	study	NOUN
gra-59	17	12	was	be	AUX
gra-59	17	13	planned	plan	VERB
gra-59	17	14	,	,	PUNCT
gra-59	17	15	including	include	VERB
gra-59	17	16	156	156	NUM
gra-59	17	17	clinically	clinically	ADV
gra-59	17	18	diagnosed	diagnose	VERB
gra-59	17	19	female	female	ADJ
gra-59	17	20	cases	case	NOUN
gra-59	17	21	of	of	ADP
gra-59	17	22	breast	breast	NOUN
gra-59	17	23	cancer	cancer	NOUN
gra-59	17	24	from	from	ADP
gra-59	17	25	opd	opd	PROPN
gra-59	17	26	/	/	SYM
gra-59	17	27	ipd	ipd	PROPN
gra-59	17	28	of	of	ADP
gra-59	17	29	surgery	surgery	NOUN
gra-59	17	30	and	and	CCONJ
gra-59	17	31	oncology	oncology	NOUN
gra-59	17	32	department	department	NOUN
gra-59	17	33	and	and	CCONJ
gra-59	17	34	same	same	ADJ
gra-59	17	35	number	number	NOUN
gra-59	17	36	of	of	ADP
gra-59	17	37	normal	normal	ADJ
gra-59	17	38	individuals	individual	NOUN
gra-59	17	39	or	or	CCONJ
gra-59	17	40	control	control	NOUN
gra-59	17	41	group	group	NOUN
gra-59	17	42	has	have	AUX
gra-59	17	43	been	be	AUX
gra-59	17	44	taken	take	VERB
gra-59	17	45	from	from	ADP
gra-59	17	46	the	the	DET
gra-59	17	47	opd	opd	PROPN
gra-59	17	48	/	/	SYM
gra-59	17	49	ipd	ipd	PROPN
gra-59	17	50	of	of	ADP
gra-59	17	51	medicine	medicine	PROPN
gra-59	17	52	department	department	PROPN
gra-59	17	53	and	and	CCONJ
gra-59	17	54	emergency	emergency	PROPN
gra-59	17	55	department	department	NOUN
gra-59	17	56	,	,	PUNCT
gra-59	17	57	s.m.s	s.m.s	NOUN
gra-59	17	58	.	.	PUNCT
gra-59	18	1	medical	medical	ADJ
gra-59	18	2	college	college	PROPN
gra-59	18	3	and	and	CCONJ
gra-59	18	4	hospital	hospital	NOUN
gra-59	18	5	,	,	PUNCT
gra-59	18	6	jaipur	jaipur	PROPN
gra-59	18	7	.	.	PUNCT
gra-59	19	1	the	the	DET
gra-59	19	2	blood	blood	NOUN
gra-59	19	3	samples	sample	NOUN
gra-59	19	4	of	of	ADP
gra-59	19	5	the	the	DET
gra-59	19	6	breast	breast	NOUN
gra-59	19	7	cancer	cancer	NOUN
gra-59	19	8	patients	patient	NOUN
gra-59	19	9	taken	take	VERB
gra-59	19	10	from	from	ADP
gra-59	19	11	outdoor	outdoor	ADJ
gra-59	19	12	&	&	CCONJ
gra-59	19	13	indoor	indoor	ADJ
gra-59	19	14	in	in	ADP
gra-59	19	15	morning	morning	NOUN
gra-59	19	16	after	after	ADP
gra-59	19	17	overnight	overnight	ADJ
gra-59	19	18	fasting	fasting	NOUN
gra-59	19	19	.	.	PUNCT
gra-59	20	1	blood	blood	NOUN
gra-59	20	2	samples	sample	NOUN
gra-59	20	3	of	of	ADP
gra-59	20	4	control	control	NOUN
gra-59	20	5	group	group	NOUN
gra-59	20	6	taken	take	VERB
gra-59	20	7	after	after	ADP
gra-59	20	8	overnight	overnight	ADJ
gra-59	20	9	fasting	fasting	NOUN
gra-59	20	10	.	.	PUNCT
gra-59	21	1	the	the	DET
gra-59	21	2	samples	sample	NOUN
gra-59	21	3	left	leave	VERB
gra-59	21	4	standing	stand	VERB
gra-59	21	5	for	for	ADP
gra-59	21	6	one	one	NUM
gra-59	21	7	hour	hour	NOUN
gra-59	21	8	;	;	PUNCT
gra-59	21	9	serum	serum	NOUN
gra-59	21	10	separated	separate	VERB
gra-59	21	11	at	at	ADP
gra-59	21	12	2500	2500	NUM
gra-59	21	13	rpm	rpm	NOUN
gra-59	21	14	centrifugation	centrifugation	NOUN
gra-59	21	15	and	and	CCONJ
gra-59	21	16	analyzed	analyze	VERB
gra-59	21	17	on	on	ADP
gra-59	21	18	fully	fully	ADV
gra-59	21	19	automated	automate	VERB
gra-59	21	20	analyzer	analyzer	NOUN
gra-59	21	21	randox(imola	randox(imola	PROPN
gra-59	21	22	)	)	PUNCT
gra-59	21	23	.	.	PUNCT
gra-59	22	1	principle	principle	NOUN
gra-59	22	2	of	of	ADP
gra-59	22	3	assay	assay	NOUN
gra-59	22	4	:	:	PUNCT
gra-59	22	5	ÿ	ÿ	X
gra-59	22	6	in	in	ADP
gra-59	22	7	this	this	DET
gra-59	22	8	study	study	NOUN
gra-59	22	9	we	we	PRON
gra-59	22	10	will	will	AUX
gra-59	22	11	investigate	investigate	VERB
gra-59	22	12	serum	serum	NOUN
gra-59	22	13	levels	level	NOUN
gra-59	22	14	of	of	ADP
gra-59	22	15	hdlcholesterol	hdlcholesterol	NOUN
gra-59	22	16	,	,	PUNCT
gra-59	22	17	ldl	ldl	NOUN
gra-59	22	18	-	-	PUNCT
gra-59	22	19	cholesterol	cholesterol	NOUN
gra-59	22	20	,	,	PUNCT
gra-59	22	21	total	total	ADJ
gra-59	22	22	cholesterol	cholesterol	NOUN
gra-59	22	23	and	and	CCONJ
gra-59	22	24	comparision	comparision	NOUN
gra-59	22	25	study	study	NOUN
gra-59	22	26	of	of	ADP
gra-59	22	27	lipid	lipid	ADJ
gra-59	22	28	profiles	profile	NOUN
gra-59	22	29	in	in	ADP
gra-59	22	30	breast	breast	NOUN
gra-59	22	31	cancer	cancer	NOUN
gra-59	22	32	patients	patient	NOUN
gra-59	22	33	and	and	CCONJ
gra-59	22	34	healthy	healthy	ADJ
gra-59	22	35	control	control	NOUN
gra-59	22	36	group	group	NOUN
gra-59	22	37	original	original	ADJ
gra-59	22	38	research	research	PROPN
gra-59	22	39	paper	paper	PROPN
gra-59	22	40	dr	dr	PROPN
gra-59	22	41	.	.	PROPN
gra-59	22	42	renu	renu	PROPN
gra-59	22	43	meena	meena	PROPN
gra-59	22	44	senior	senior	PROPN
gra-59	22	45	demonstrator	demonstrator	NOUN
gra-59	22	46	,	,	PUNCT
gra-59	22	47	department	department	NOUN
gra-59	22	48	of	of	ADP
gra-59	22	49	biochemistry	biochemistry	NOUN
gra-59	22	50	,	,	PUNCT
gra-59	22	51	r.n.t	r.n.t	NOUN
gra-59	22	52	.	.	PUNCT
gra-59	22	53	medical	medical	PROPN
gra-59	22	54	college	college	PROPN
gra-59	22	55	,	,	PUNCT
gra-59	22	56	udaipur	udaipur	PROPN
gra-59	22	57	(	(	PUNCT
gra-59	22	58	rajasthan	rajasthan	PROPN
gra-59	22	59	)	)	PUNCT
gra-59	22	60	x	x	SYM
gra-59	23	1	55gjra	55gjra	NUM
gra-59	23	2	global	global	ADJ
gra-59	23	3	journal	journal	PROPN
gra-59	23	4	for	for	ADP
gra-59	23	5	research	research	NOUN
gra-59	23	6	analysis	analysis	NOUN
gra-59	23	7	medical	medical	ADJ
gra-59	23	8	science	science	NOUN
gra-59	23	9	carcinoma	carcinoma	NOUN
gra-59	23	10	of	of	ADP
gra-59	23	11	the	the	DET
gra-59	23	12	breast	breast	NOUN
gra-59	23	13	is	be	AUX
gra-59	23	14	the	the	DET
gra-59	23	15	second	second	ADJ
gra-59	23	16	commonest	commonest	NOUN
gra-59	23	17	malignancy	malignancy	NOUN
gra-59	23	18	affecting	affect	VERB
gra-59	23	19	half	half	DET
gra-59	23	20	a	a	DET
gra-59	23	21	million	million	NUM
gra-59	23	22	women	woman	NOUN
gra-59	23	23	worldwide	worldwide	ADV
gra-59	23	24	each	each	DET
gra-59	23	25	year	year	NOUN
gra-59	23	26	.	.	PUNCT
gra-59	24	1	epidemiological	epidemiological	ADJ
gra-59	24	2	studies	study	NOUN
gra-59	24	3	have	have	AUX
gra-59	24	4	revealed	reveal	VERB
gra-59	24	5	that	that	SCONJ
gra-59	24	6	1	1	NUM
gra-59	24	7	in	in	ADP
gra-59	24	8	50	50	NUM
gra-59	24	9	women	woman	NOUN
gra-59	24	10	in	in	ADP
gra-59	24	11	india	india	PROPN
gra-59	24	12	can	can	AUX
gra-59	24	13	develop	develop	VERB
gra-59	24	14	breast	breast	NOUN
gra-59	24	15	cancer	cancer	NOUN
gra-59	24	16	in	in	ADP
gra-59	24	17	their	their	PRON
gra-59	24	18	lifetime	lifetime	NOUN
gra-59	24	19	.	.	PUNCT
gra-59	25	1	a	a	DET
gra-59	25	2	number	number	NOUN
gra-59	25	3	of	of	ADP
gra-59	25	4	epidemiological	epidemiological	ADJ
gra-59	25	5	studies	study	NOUN
gra-59	25	6	have	have	AUX
gra-59	25	7	shown	show	VERB
gra-59	25	8	the	the	DET
gra-59	25	9	increased	increase	VERB
gra-59	25	10	risk	risk	NOUN
gra-59	25	11	of	of	ADP
gra-59	25	12	death	death	NOUN
gra-59	25	13	from	from	ADP
gra-59	25	14	cancer	cancer	NOUN
gra-59	25	15	with	with	ADP
gra-59	25	16	hypocholesterolaemia	hypocholesterolaemia	NOUN
gra-59	25	17	,	,	PUNCT
gra-59	25	18	although	although	SCONJ
gra-59	25	19	several	several	ADJ
gra-59	25	20	studies	study	NOUN
gra-59	25	21	proposed	propose	VERB
gra-59	25	22	the	the	DET
gra-59	25	23	low	low	ADJ
gra-59	25	24	levels	level	NOUN
gra-59	25	25	of	of	ADP
gra-59	25	26	cholesterol	cholesterol	NOUN
gra-59	25	27	is	be	AUX
gra-59	25	28	a	a	DET
gra-59	25	29	predisposing	predispose	VERB
gra-59	25	30	factor	factor	NOUN
gra-59	25	31	for	for	ADP
gra-59	25	32	carcinogenesis	carcinogenesis	NOUN
gra-59	25	33	.	.	PUNCT
gra-59	26	1	so	so	ADV
gra-59	26	2	the	the	DET
gra-59	26	3	present	present	ADJ
gra-59	26	4	study	study	NOUN
gra-59	26	5	was	be	AUX
gra-59	26	6	planned	plan	VERB
gra-59	26	7	to	to	PART
gra-59	26	8	investigate	investigate	VERB
gra-59	26	9	the	the	DET
gra-59	26	10	alteration	alteration	NOUN
gra-59	26	11	in	in	ADP
gra-59	26	12	the	the	DET
gra-59	26	13	lipid	lipid	ADJ
gra-59	26	14	proles	prole	NOUN
gra-59	26	15	of	of	ADP
gra-59	26	16	patients	patient	NOUN
gra-59	26	17	with	with	ADP
gra-59	26	18	carcinoma	carcinoma	NOUN
gra-59	26	19	of	of	ADP
gra-59	26	20	breast	breast	NOUN
gra-59	26	21	in	in	ADP
gra-59	26	22	comparison	comparison	NOUN
gra-59	26	23	with	with	ADP
gra-59	26	24	age	age	NOUN
gra-59	26	25	matched	match	VERB
gra-59	26	26	control	control	NOUN
gra-59	26	27	women	woman	NOUN
gra-59	26	28	.	.	PUNCT
gra-59	27	1	aim	aim	VERB
gra-59	27	2	:	:	PUNCT
gra-59	27	3	estimate	estimate	VERB
gra-59	27	4	and	and	CCONJ
gra-59	27	5	compare	compare	VERB
gra-59	27	6	serum	serum	NOUN
gra-59	27	7	lipid	lipid	NOUN
gra-59	27	8	prole	prole	PROPN
gra-59	27	9	for	for	ADP
gra-59	27	10	both	both	PRON
gra-59	27	11	in	in	ADP
gra-59	27	12	breast	breast	NOUN
gra-59	27	13	cancer	cancer	NOUN
gra-59	27	14	patients	patient	NOUN
gra-59	27	15	and	and	CCONJ
gra-59	27	16	normal	normal	ADJ
gra-59	27	17	individuals	individual	NOUN
gra-59	27	18	.	.	PUNCT
gra-59	28	1	materials	material	NOUN
gra-59	28	2	&	&	CCONJ
gra-59	28	3	methods	method	NOUN
gra-59	28	4	:	:	PUNCT
gra-59	28	5	overnight	overnight	ADV
gra-59	28	6	fasting	fast	VERB
gra-59	28	7	blood	blood	NOUN
gra-59	28	8	samples	sample	NOUN
gra-59	28	9	of	of	ADP
gra-59	28	10	156	156	NUM
gra-59	28	11	clinically	clinically	ADV
gra-59	28	12	diagnosed	diagnose	VERB
gra-59	28	13	female	female	ADJ
gra-59	28	14	cases	case	NOUN
gra-59	28	15	of	of	ADP
gra-59	28	16	breast	breast	NOUN
gra-59	28	17	cancer	cancer	NOUN
gra-59	28	18	from	from	ADP
gra-59	28	19	opd	opd	PROPN
gra-59	28	20	/	/	SYM
gra-59	28	21	ipd	ipd	PROPN
gra-59	28	22	of	of	ADP
gra-59	28	23	surgery	surgery	NOUN
gra-59	28	24	and	and	CCONJ
gra-59	28	25	oncology	oncology	NOUN
gra-59	28	26	department	department	NOUN
gra-59	28	27	and	and	CCONJ
gra-59	28	28	same	same	ADJ
gra-59	28	29	number	number	NOUN
gra-59	28	30	of	of	ADP
gra-59	28	31	normal	normal	ADJ
gra-59	28	32	individuals	individual	NOUN
gra-59	28	33	or	or	CCONJ
gra-59	28	34	control	control	NOUN
gra-59	28	35	group	group	NOUN
gra-59	28	36	has	have	AUX
gra-59	28	37	been	be	AUX
gra-59	28	38	taken	take	VERB
gra-59	28	39	from	from	ADP
gra-59	28	40	the	the	DET
gra-59	28	41	opd	opd	PROPN
gra-59	28	42	/	/	SYM
gra-59	28	43	ipd	ipd	PROPN
gra-59	28	44	of	of	ADP
gra-59	28	45	medicine	medicine	PROPN
gra-59	28	46	department	department	PROPN
gra-59	28	47	and	and	CCONJ
gra-59	28	48	emergency	emergency	PROPN
gra-59	28	49	department	department	NOUN
gra-59	28	50	,	,	PUNCT
gra-59	28	51	s.m.s	s.m.s	NOUN
gra-59	28	52	.	.	PUNCT
gra-59	29	1	medical	medical	ADJ
gra-59	29	2	college	college	PROPN
gra-59	29	3	and	and	CCONJ
gra-59	29	4	hospital	hospital	NOUN
gra-59	29	5	,	,	PUNCT
gra-59	29	6	jaipur.esmination	jaipur.esmination	NOUN
gra-59	29	7	of	of	ADP
gra-59	29	8	serum	serum	NOUN
gra-59	29	9	lipid	lipid	NOUN
gra-59	29	10	proles	prole	NOUN
gra-59	29	11	such	such	ADJ
gra-59	29	12	as	as	ADP
gra-59	29	13	total	total	ADJ
gra-59	29	14	cholesterol	cholesterol	NOUN
gra-59	29	15	,	,	PUNCT
gra-59	29	16	hdl	hdl	NOUN
gra-59	29	17	-	-	PUNCT
gra-59	29	18	cholesterol	cholesterol	NOUN
gra-59	29	19	,	,	PUNCT
gra-59	29	20	etc	etc	X
gra-59	29	21	.	.	X
gra-59	29	22	were	be	AUX
gra-59	29	23	determine	determine	VERB
gra-59	29	24	by	by	ADP
gra-59	29	25	enzymatic	enzymatic	ADJ
gra-59	29	26	method	method	NOUN
gra-59	29	27	in	in	ADP
gra-59	29	28	fully	fully	ADV
gra-59	29	29	automated	automate	VERB
gra-59	29	30	chemistry	chemistry	NOUN
gra-59	29	31	analyzer	analyzer	NOUN
gra-59	29	32	.	.	PUNCT
gra-59	30	1	observation	observation	NOUN
gra-59	30	2	&	&	CCONJ
gra-59	30	3	result	result	PROPN
gra-59	30	4	:	:	PUNCT
gra-59	30	5	mean±sd	mean±sd	ADP
gra-59	30	6	(	(	PUNCT
gra-59	30	7	mg	mg	PROPN
gra-59	30	8	/	/	SYM
gra-59	30	9	dl	dl	NOUN
gra-59	30	10	)	)	PUNCT
gra-59	30	11	for	for	ADP
gra-59	30	12	serum	serum	NOUN
gra-59	30	13	tg	tg	PROPN
gra-59	30	14	level	level	NOUN
gra-59	30	15	,	,	PUNCT
gra-59	30	16	in	in	ADP
gra-59	30	17	case	case	NOUN
gra-59	30	18	of	of	ADP
gra-59	30	19	breast	breast	NOUN
gra-59	30	20	cancer	cancer	NOUN
gra-59	30	21	patients	patient	NOUN
gra-59	30	22	&	&	CCONJ
gra-59	30	23	control	control	PROPN
gra-59	30	24	group	group	PROPN
gra-59	30	25	were	be	AUX
gra-59	30	26	202.74±53.45	202.74±53.45	NUM
gra-59	30	27	and	and	CCONJ
gra-59	30	28	178.77±99.36	178.77±99.36	NUM
gra-59	30	29	respectively	respectively	ADV
gra-59	30	30	and	and	CCONJ
gra-59	30	31	p	p	NOUN
gra-59	30	32	value	value	NOUN
gra-59	30	33	was	be	AUX
gra-59	30	34	0.008	0.008	NUM
gra-59	30	35	.	.	PUNCT
gra-59	31	1	similarly	similarly	ADV
gra-59	31	2	,	,	PUNCT
gra-59	31	3	for	for	ADP
gra-59	31	4	serum	serum	NOUN
gra-59	31	5	cholesterol	cholesterol	NOUN
gra-59	31	6	were	be	AUX
gra-59	31	7	205.62±46.09	205.62±46.09	NUM
gra-59	31	8	and	and	CCONJ
gra-59	31	9	158.73±41.59	158.73±41.59	NUM
gra-59	31	10	for	for	ADP
gra-59	31	11	breast	breast	NOUN
gra-59	31	12	cancer	cancer	NOUN
gra-59	31	13	and	and	CCONJ
gra-59	31	14	control	control	NOUN
gra-59	31	15	group	group	NOUN
gra-59	31	16	respectively.also	respectively.also	NOUN
gra-59	31	17	,	,	PUNCT
gra-59	31	18	p	p	NOUN
gra-59	31	19	value	value	NOUN
gra-59	31	20	of	of	ADP
gra-59	31	21	s.cholesterol	s.cholesterol	NOUN
gra-59	31	22	was	be	AUX
gra-59	31	23	0.000	0.000	NUM
gra-59	31	24	.	.	PUNCT
gra-59	32	1	mean	mean	VERB
gra-59	32	2	and	and	CCONJ
gra-59	32	3	sd	sd	NOUN
gra-59	32	4	of	of	ADP
gra-59	32	5	s.hdl	s.hdl	ADJ
gra-59	32	6	-	-	PUNCT
gra-59	32	7	cholesterol	cholesterol	NOUN
gra-59	32	8	level	level	NOUN
gra-59	32	9	for	for	ADP
gra-59	32	10	both	both	CCONJ
gra-59	32	11	the	the	DET
gra-59	32	12	groups	group	NOUN
gra-59	32	13	were	be	AUX
gra-59	32	14	39.20±5.30	39.20±5.30	NUM
gra-59	32	15	and	and	CCONJ
gra-59	32	16	40.46±8.96	40.46±8.96	NUM
gra-59	32	17	respectively	respectively	ADV
gra-59	32	18	,	,	PUNCT
gra-59	32	19	p	p	PRON
gra-59	32	20	value	value	NOUN
gra-59	32	21	was	be	AUX
gra-59	32	22	non	non	X
gra-59	32	23	signicant	signicant	ADJ
gra-59	32	24	.	.	PUNCT
gra-59	33	1	as	as	ADV
gra-59	33	2	far	far	ADV
gra-59	33	3	as	as	ADP
gra-59	33	4	s.ldl	s.ldl	NOUN
gra-59	33	5	level	level	NOUN
gra-59	33	6	was	be	AUX
gra-59	33	7	concert	concert	ADJ
gra-59	33	8	for	for	SCONJ
gra-59	33	9	breast	breast	NOUN
gra-59	33	10	cancer	cancer	NOUN
gra-59	33	11	patients	patient	NOUN
gra-59	33	12	was	be	AUX
gra-59	33	13	125.87±46.97	125.87±46.97	NOUN
gra-59	33	14	and	and	CCONJ
gra-59	33	15	for	for	SCONJ
gra-59	33	16	the	the	DET
gra-59	33	17	control	control	NOUN
gra-59	33	18	group	group	NOUN
gra-59	33	19	was	be	AUX
gra-59	33	20	81.54±29.21	81.54±29.21	NUM
gra-59	33	21	and	and	CCONJ
gra-59	33	22	p	p	NOUN
gra-59	33	23	value	value	NOUN
gra-59	33	24	was	be	AUX
gra-59	33	25	0.000	0.000	NUM
gra-59	33	26	.	.	PUNCT
gra-59	34	1	level	level	NOUN
gra-59	34	2	of	of	ADP
gra-59	34	3	s.	s.	PROPN
gra-59	34	4	vldl	vldl	PROPN
gra-59	34	5	were	be	AUX
gra-59	34	6	40.55±10.69	40.55±10.69	NOUN
gra-59	34	7	and	and	CCONJ
gra-59	34	8	35.70±19.49	35.70±19.49	NUM
gra-59	34	9	for	for	ADP
gra-59	34	10	test	test	NOUN
gra-59	34	11	group	group	NOUN
gra-59	34	12	and	and	CCONJ
gra-59	34	13	control	control	NOUN
gra-59	34	14	group	group	NOUN
gra-59	34	15	respectively	respectively	ADV
gra-59	34	16	and	and	CCONJ
gra-59	34	17	p	p	NOUN
gra-59	34	18	value	value	NOUN
gra-59	34	19	was	be	AUX
gra-59	34	20	0.008	0.008	NUM
gra-59	34	21	.	.	PUNCT
gra-59	35	1	summary	summary	NOUN
gra-59	35	2	&	&	CCONJ
gra-59	35	3	conclusion	conclusion	NOUN
gra-59	35	4	:	:	PUNCT
gra-59	35	5	serum	serum	NOUN
gra-59	35	6	cholesterol	cholesterol	NOUN
gra-59	35	7	,	,	PUNCT
gra-59	35	8	serum	serum	NOUN
gra-59	35	9	ldl	ldl	NOUN
gra-59	35	10	was	be	AUX
gra-59	35	11	signicantly	signicantly	ADV
gra-59	35	12	lower	low	ADJ
gra-59	35	13	in	in	ADP
gra-59	35	14	breast	breast	NOUN
gra-59	35	15	cancer	cancer	NOUN
gra-59	35	16	patients	patient	NOUN
gra-59	35	17	whereas	whereas	SCONJ
gra-59	35	18	serum	serum	PROPN
gra-59	35	19	tg	tg	PROPN
gra-59	35	20	,	,	PUNCT
gra-59	35	21	vldl	vldl	PROPN
gra-59	35	22	was	be	AUX
gra-59	35	23	signicantly	signicantly	ADV
gra-59	35	24	higher	high	ADJ
gra-59	35	25	in	in	ADP
gra-59	35	26	breast	breast	NOUN
gra-59	35	27	cancer	cancer	NOUN
gra-59	35	28	patients	patient	NOUN
gra-59	35	29	.	.	PUNCT
gra-59	36	1	carcinoma	carcinoma	NOUN
gra-59	36	2	breast	breast	NOUN
gra-59	36	3	is	be	AUX
gra-59	36	4	commonest	commonest	NOUN
gra-59	36	5	cancer	cancer	NOUN
gra-59	36	6	in	in	ADP
gra-59	36	7	urban	urban	ADJ
gra-59	36	8	and	and	CCONJ
gra-59	36	9	rural	rural	ADJ
gra-59	36	10	females	female	NOUN
gra-59	36	11	.	.	PUNCT
gra-59	37	1	many	many	ADJ
gra-59	37	2	women	woman	NOUN
gra-59	37	3	donot	donot	PROPN
gra-59	37	4	present	present	VERB
gra-59	37	5	themselves	themselves	PRON
gra-59	37	6	for	for	ADP
gra-59	37	7	check	check	NOUN
gra-59	37	8	-	-	PUNCT
gra-59	37	9	up	up	NOUN
gra-59	37	10	at	at	ADP
gra-59	37	11	hospitals	hospital	NOUN
gra-59	37	12	or	or	CCONJ
gra-59	37	13	medical	medical	ADJ
gra-59	37	14	because	because	SCONJ
gra-59	37	15	of	of	ADP
gra-59	37	16	varied	varied	ADJ
gra-59	37	17	reasons	reason	NOUN
gra-59	37	18	like	like	ADP
gra-59	37	19	illiteracy	illiteracy	NOUN
gra-59	37	20	,	,	PUNCT
gra-59	37	21	monetary	monetary	ADJ
gra-59	37	22	reasons	reason	NOUN
gra-59	37	23	and	and	CCONJ
gra-59	37	24	lack	lack	NOUN
gra-59	37	25	of	of	ADP
gra-59	37	26	knowledge	knowledge	NOUN
gra-59	37	27	.	.	PUNCT
gra-59	38	1	.lots	.lot	NOUN
gra-59	38	2	of	of	ADP
gra-59	38	3	efforts	effort	NOUN
gra-59	38	4	are	be	AUX
gra-59	38	5	needed	need	VERB
gra-59	38	6	both	both	CCONJ
gra-59	38	7	from	from	ADP
gra-59	38	8	the	the	DET
gra-59	38	9	health	health	NOUN
gra-59	38	10	systems	system	NOUN
gra-59	38	11	as	as	ADV
gra-59	38	12	well	well	ADV
gra-59	38	13	as	as	ADP
gra-59	38	14	from	from	ADP
gra-59	38	15	local	local	ADJ
gra-59	38	16	population	population	NOUN
gra-59	38	17	for	for	ADP
gra-59	38	18	early	early	ADJ
gra-59	38	19	diagnosis	diagnosis	NOUN
gra-59	38	20	of	of	ADP
gra-59	38	21	cancer	cancer	NOUN
gra-59	38	22	breast	breast	NOUN
gra-59	38	23	abstract	abstract	ADJ
gra-59	38	24	keywords	keyword	NOUN
gra-59	38	25	:	:	PUNCT
gra-59	38	26	breast	breast	NOUN
gra-59	38	27	cancer	cancer	NOUN
gra-59	38	28	,	,	PUNCT
gra-59	38	29	hdl	hdl	PROPN
gra-59	38	30	,	,	PUNCT
gra-59	38	31	vldl	vldl	NOUN
gra-59	38	32	,	,	PUNCT
gra-59	38	33	ldl	ldl	NOUN
gra-59	38	34	,	,	PUNCT
gra-59	38	35	cholesterol	cholesterol	PROPN
gra-59	38	36	dr	dr	PROPN
gra-59	38	37	.	.	PROPN
gra-59	38	38	shakuntala	shakuntala	PROPN
gra-59	38	39	saini	saini	PROPN
gra-59	38	40	professor	professor	PROPN
gra-59	38	41	,	,	PUNCT
gra-59	38	42	department	department	NOUN
gra-59	38	43	of	of	ADP
gra-59	38	44	biochemistry	biochemistry	NOUN
gra-59	38	45	,	,	PUNCT
gra-59	38	46	s.m.s	s.m.s	NOUN
gra-59	38	47	.	.	PUNCT
gra-59	39	1	medical	medical	ADJ
gra-59	39	2	college	college	PROPN
gra-59	39	3	,	,	PUNCT
gra-59	39	4	jaipur	jaipur	PROPN
gra-59	39	5	(	(	PUNCT
gra-59	39	6	rajasthan)*corresponding	rajasthan)*corresponde	VERB
gra-59	39	7	author	author	NOUN
gra-59	39	8	volume-8	volume-8	NUM
gra-59	39	9	,	,	PUNCT
gra-59	39	10	issue-9	issue-9	NUM
gra-59	39	11	,	,	PUNCT
gra-59	39	12	september-2019	september-2019	ADJ
gra-59	39	13	•	•	NUM
gra-59	39	14	print	print	NOUN
gra-59	39	15	issn	issn	PROPN
gra-59	39	16	no	no	NOUN
gra-59	39	17	.	.	PROPN
gra-59	39	18	2277	2277	NUM
gra-59	39	19	8160	8160	NUM
gra-59	39	20	•	•	NOUN
gra-59	39	21	doi	doi	NOUN
gra-59	39	22	:	:	PUNCT
gra-59	39	23	10.36106	10.36106	NUM
gra-59	39	24	/	/	SYM
gra-59	39	25	gjra	gjra	NOUN
gra-59	39	26	56	56	NUM
gra-59	39	27	x	x	NOUN
gra-59	39	28	gjra	gjra	ADJ
gra-59	39	29	global	global	ADJ
gra-59	39	30	journal	journal	PROPN
gra-59	39	31	for	for	ADP
gra-59	39	32	research	research	NOUN
gra-59	39	33	analysis	analysis	NOUN
gra-59	39	34	triglycerides	triglyceride	NOUN
gra-59	39	35	in	in	ADP
gra-59	39	36	breast	breast	NOUN
gra-59	39	37	cancer	cancer	NOUN
gra-59	39	38	patient	patient	NOUN
gra-59	39	39	and	and	CCONJ
gra-59	39	40	healthy	healthy	ADJ
gra-59	39	41	controls	control	NOUN
gra-59	39	42	.	.	PUNCT
gra-59	40	1	ÿ	ÿ	PROPN
gra-59	40	2	serum	serum	NOUN
gra-59	40	3	levels	level	NOUN
gra-59	40	4	of	of	ADP
gra-59	40	5	lipids	lipid	NOUN
gra-59	40	6	will	will	AUX
gra-59	40	7	be	be	AUX
gra-59	40	8	measured	measure	VERB
gra-59	40	9	by	by	ADP
gra-59	40	10	colorimetric	colorimetric	ADJ
gra-59	40	11	technique	technique	NOUN
gra-59	40	12	in	in	ADP
gra-59	40	13	fully	fully	ADV
gra-59	40	14	automated	automate	VERB
gra-59	40	15	chemistry	chemistry	NOUN
gra-59	40	16	analyzer	analyzer	NOUN
gra-59	40	17	randox(imola	randox(imola	PROPN
gra-59	40	18	)	)	PUNCT
gra-59	40	19	methodology	methodology	NOUN
gra-59	40	20	ÿ	ÿ	DET
gra-59	40	21	estimation	estimation	NOUN
gra-59	40	22	of	of	ADP
gra-59	40	23	total	total	ADJ
gra-59	40	24	cholesterol	cholesterol	NOUN
gra-59	40	25	:	:	PUNCT
gra-59	40	26	enzymatic	enzymatic	ADJ
gra-59	40	27	method	method	NOUN
gra-59	40	28	(	(	PUNCT
gra-59	40	29	chodpap	chodpap	NOUN
gra-59	40	30	)	)	PUNCT
gra-59	40	31	principle	principle	NOUN
gra-59	40	32	the	the	DET
gra-59	40	33	enzyme	enzyme	NOUN
gra-59	40	34	cholesterol	cholesterol	NOUN
gra-59	40	35	esterase	esterase	NOUN
gra-59	40	36	is	be	AUX
gra-59	40	37	used	use	VERB
gra-59	40	38	to	to	PART
gra-59	40	39	hydrolyze	hydrolyze	VERB
gra-59	40	40	the	the	DET
gra-59	40	41	cholesterol	cholesterol	NOUN
gra-59	40	42	esters	ester	NOUN
gra-59	40	43	present	present	ADJ
gra-59	40	44	in	in	ADP
gra-59	40	45	the	the	DET
gra-59	40	46	serum	serum	NOUN
gra-59	40	47	to	to	PART
gra-59	40	48	free	free	VERB
gra-59	40	49	cholesterol	cholesterol	NOUN
gra-59	40	50	and	and	CCONJ
gra-59	40	51	free	free	ADJ
gra-59	40	52	fatty	fatty	NOUN
gra-59	40	53	acids	acid	NOUN
gra-59	40	54	.	.	PUNCT
gra-59	41	1	the	the	DET
gra-59	41	2	enzyme	enzyme	NOUN
gra-59	41	3	cholesterol	cholesterol	NOUN
gra-59	41	4	oxidase	oxidase	NOUN
gra-59	41	5	in	in	ADP
gra-59	41	6	the	the	DET
gra-59	41	7	presence	presence	NOUN
gra-59	41	8	of	of	ADP
gra-59	41	9	oxygen	oxygen	NOUN
gra-59	41	10	to	to	PART
gra-59	41	11	oxidizes	oxidize	VERB
gra-59	41	12	the	the	DET
gra-59	41	13	cholesterol	cholesterol	NOUN
gra-59	41	14	to	to	ADP
gra-59	41	15	cholest-4	cholest-4	NOUN
gra-59	41	16	-	-	PUNCT
gra-59	41	17	en3one	en3one	NOUN
gra-59	41	18	and	and	CCONJ
gra-59	41	19	hydrogen	hydrogen	NOUN
gra-59	41	20	peroxide	peroxide	NOUN
gra-59	41	21	.	.	PUNCT
gra-59	42	1	hydrogen	hydrogen	NOUN
gra-59	42	2	peroxide	peroxide	NOUN
gra-59	42	3	oxidizes	oxidize	VERB
gra-59	42	4	phenol	phenol	NOUN
gra-59	42	5	and	and	CCONJ
gra-59	42	6	4	4	NUM
gra-59	42	7	-	-	NOUN
gra-59	42	8	aminoantipyrine	aminoantipyrine	NOUN
gra-59	42	9	to	to	PART
gra-59	42	10	produce	produce	VERB
gra-59	42	11	red	red	ADJ
gra-59	42	12	color	color	NOUN
gra-59	42	13	that	that	PRON
gra-59	42	14	can	can	AUX
gra-59	42	15	be	be	AUX
gra-59	42	16	measured	measure	VERB
gra-59	42	17	spectrophotometrically	spectrophotometrically	ADV
gra-59	42	18	.	.	PUNCT
gra-59	43	1	calculation	calculation	NOUN
gra-59	43	2	:	:	PUNCT
gra-59	43	3	normal	normal	ADJ
gra-59	43	4	value	value	NOUN
gra-59	43	5	total	total	ADJ
gra-59	43	6	cholesterol	cholesterol	NOUN
gra-59	43	7	desirable	desirable	ADJ
gra-59	43	8	:	:	PUNCT
gra-59	43	9	<	<	X
gra-59	43	10	200	200	NUM
gra-59	43	11	mg	mg	PROPN
gra-59	43	12	/	/	SYM
gra-59	43	13	dl	dl	PROPN
gra-59	43	14	borderline	borderline	NOUN
gra-59	43	15	high	high	ADV
gra-59	43	16	:	:	PUNCT
gra-59	43	17	200	200	NUM
gra-59	43	18	-239	-239	PROPN
gra-59	43	19	mg	mg	PROPN
gra-59	43	20	/	/	SYM
gra-59	43	21	dl	dl	PROPN
gra-59	43	22	high	high	ADV
gra-59	43	23	:	:	PUNCT
gra-59	43	24	>	>	X
gra-59	43	25	or	or	CCONJ
gra-59	43	26	=	=	SYM
gra-59	43	27	240	240	NUM
gra-59	43	28	mg	mg	PROPN
gra-59	43	29	/	/	SYM
gra-59	43	30	dl	dl	PROPN
gra-59	43	31	ÿ	ÿ	PROPN
gra-59	43	32	estimation	estimation	NOUN
gra-59	43	33	of	of	ADP
gra-59	43	34	serum	serum	PROPN
gra-59	43	35	hdl	hdl	PROPN
gra-59	43	36	-	-	PUNCT
gra-59	43	37	cholesterol	cholesterol	NOUN
gra-59	43	38	:	:	PUNCT
gra-59	43	39	principle	principle	NOUN
gra-59	43	40	:	:	PUNCT
gra-59	43	41	the	the	DET
gra-59	43	42	method	method	NOUN
gra-59	43	43	is	be	AUX
gra-59	43	44	in	in	ADP
gra-59	43	45	a	a	DET
gra-59	43	46	two	two	NUM
gra-59	43	47	reagent	reagent	ADJ
gra-59	43	48	format	format	NOUN
gra-59	43	49	and	and	CCONJ
gra-59	43	50	depends	depend	VERB
gra-59	43	51	on	on	ADP
gra-59	43	52	the	the	DET
gra-59	43	53	properties	property	NOUN
gra-59	43	54	of	of	ADP
gra-59	43	55	a	a	DET
gra-59	43	56	unique	unique	ADJ
gra-59	43	57	detergent	detergent	NOUN
gra-59	43	58	,	,	PUNCT
gra-59	43	59	as	as	SCONJ
gra-59	43	60	illustrated	illustrate	VERB
gra-59	43	61	.	.	PUNCT
gra-59	44	1	this	this	DET
gra-59	44	2	method	method	NOUN
gra-59	44	3	is	be	AUX
gra-59	44	4	based	base	VERB
gra-59	44	5	on	on	ADP
gra-59	44	6	accelerating	accelerate	VERB
gra-59	44	7	the	the	DET
gra-59	44	8	reaction	reaction	NOUN
gra-59	44	9	of	of	ADP
gra-59	44	10	cholesterol	cholesterol	NOUN
gra-59	44	11	oxidase	oxidase	NOUN
gra-59	44	12	(	(	PUNCT
gra-59	44	13	co	co	NOUN
gra-59	44	14	)	)	PUNCT
gra-59	44	15	with	with	ADP
gra-59	44	16	non	non	ADJ
gra-59	44	17	-	-	ADJ
gra-59	44	18	hdl	hdl	ADJ
gra-59	44	19	un	un	PROPN
gra-59	44	20	-	-	PROPN
gra-59	44	21	esteried	esteried	PROPN
gra-59	44	22	cholesterol	cholesterol	NOUN
gra-59	44	23	and	and	CCONJ
gra-59	44	24	dissolving	dissolve	VERB
gra-59	44	25	hdl	hdl	NOUN
gra-59	44	26	selectivity	selectivity	NOUN
gra-59	44	27	using	use	VERB
gra-59	44	28	a	a	DET
gra-59	44	29	specic	specic	NOUN
gra-59	44	30	detergent	detergent	NOUN
gra-59	44	31	.	.	PUNCT
gra-59	45	1	in	in	ADP
gra-59	45	2	the	the	DET
gra-59	45	3	rst	rst	PROPN
gra-59	45	4	reagent	reagent	NOUN
gra-59	45	5	,	,	PUNCT
gra-59	45	6	non	non	ADJ
gra-59	45	7	-	-	ADJ
gra-59	45	8	hdl	hdl	ADJ
gra-59	45	9	unesteried	unesteried	PROPN
gra-59	45	10	cholesterol	cholesterol	NOUN
gra-59	45	11	is	be	AUX
gra-59	45	12	subject	subject	ADJ
gra-59	45	13	to	to	ADP
gra-59	45	14	an	an	DET
gra-59	45	15	enzyme	enzyme	NOUN
gra-59	45	16	reaction	reaction	NOUN
gra-59	45	17	and	and	CCONJ
gra-59	45	18	peroxide	peroxide	NOUN
gra-59	45	19	generated	generate	VERB
gra-59	45	20	is	be	AUX
gra-59	45	21	consumed	consume	VERB
gra-59	45	22	by	by	ADP
gra-59	45	23	a	a	DET
gra-59	45	24	peroxidase	peroxidase	NOUN
gra-59	45	25	reaction	reaction	NOUN
gra-59	45	26	with	with	ADP
gra-59	45	27	dsbmt	dsbmt	NOUN
gra-59	45	28	yielding	yield	VERB
gra-59	45	29	a	a	DET
gra-59	45	30	colorless	colorless	ADJ
gra-59	45	31	product	product	NOUN
gra-59	45	32	.	.	PUNCT
gra-59	46	1	the	the	DET
gra-59	46	2	second	second	ADJ
gra-59	46	3	reagent	reagent	NOUN
gra-59	46	4	consists	consist	VERB
gra-59	46	5	of	of	ADP
gra-59	46	6	a	a	DET
gra-59	46	7	detergent	detergent	NOUN
gra-59	46	8	capable	capable	ADJ
gra-59	46	9	of	of	ADP
gra-59	46	10	solubilizing	solubilize	VERB
gra-59	46	11	hdl	hdl	PROPN
gra-59	46	12	specically	specically	PROPN
gra-59	46	13	,	,	PUNCT
gra-59	46	14	cholesterol	cholesterol	NOUN
gra-59	46	15	esterase	esterase	NOUN
gra-59	46	16	(	(	PUNCT
gra-59	46	17	ce	ce	PROPN
gra-59	46	18	)	)	PUNCT
gra-59	46	19	and	and	CCONJ
gra-59	46	20	chromagenic	chromagenic	ADJ
gra-59	46	21	coupler	coupler	NOUN
gra-59	46	22	to	to	PART
gra-59	46	23	develop	develop	VERB
gra-59	46	24	color	color	NOUN
gra-59	46	25	for	for	ADP
gra-59	46	26	the	the	DET
gra-59	46	27	quantitative	quantitative	ADJ
gra-59	46	28	determination	determination	NOUN
gra-59	46	29	of	of	ADP
gra-59	46	30	hdl	hdl	PROPN
gra-59	46	31	cholesterol	cholesterol	PROPN
gra-59	46	32	.	.	PUNCT
gra-59	47	1	this	this	PRON
gra-59	47	2	may	may	AUX
gra-59	47	3	be	be	AUX
gra-59	47	4	referred	refer	VERB
gra-59	47	5	to	to	ADP
gra-59	47	6	as	as	ADP
gra-59	47	7	the	the	DET
gra-59	47	8	accelerator	accelerator	NOUN
gra-59	47	9	selective	selective	ADJ
gra-59	47	10	detergent	detergent	NOUN
gra-59	47	11	methodology	methodology	NOUN
gra-59	47	12	.	.	PUNCT
gra-59	48	1	expected	expect	VERB
gra-59	48	2	values	value	NOUN
gra-59	48	3	hdl	hdl	PROPN
gra-59	48	4	cholesterol	cholesterol	PROPN
gra-59	48	5	low	low	PROPN
gra-59	48	6	hdl	hdl	PROPN
gra-59	48	7	:	:	PUNCT
gra-59	48	8	<	<	X
gra-59	48	9	40	40	NUM
gra-59	48	10	mg	mg	PROPN
gra-59	48	11	/	/	SYM
gra-59	48	12	dl	dl	PROPN
gra-59	48	13	borderline	borderline	NOUN
gra-59	48	14	low	low	ADJ
gra-59	48	15	:	:	PUNCT
gra-59	48	16	40	40	NUM
gra-59	48	17	-	-	SYM
gra-59	48	18	59	59	NUM
gra-59	48	19	mg	mg	PROPN
gra-59	48	20	/	/	SYM
gra-59	48	21	dl	dl	PROPN
gra-59	48	22	normal	normal	ADJ
gra-59	48	23	:	:	PUNCT
gra-59	48	24	>	>	X
gra-59	48	25	or	or	CCONJ
gra-59	48	26	=	=	SYM
gra-59	48	27	60	60	NUM
gra-59	48	28	mg	mg	NUM
gra-59	48	29	/	/	SYM
gra-59	48	30	dl	dl	PROPN
gra-59	48	31	ÿ	ÿ	PRON
gra-59	48	32	estimation	estimation	NOUN
gra-59	48	33	of	of	ADP
gra-59	48	34	serum	serum	NOUN
gra-59	48	35	triglycerides:(gpo	triglycerides:(gpo	NOUN
gra-59	48	36	-	-	PUNCT
gra-59	48	37	pap	pap	NOUN
gra-59	48	38	method	method	NOUN
gra-59	48	39	)	)	PUNCT
gra-59	48	40	principle	principle	NOUN
gra-59	48	41	:	:	PUNCT
gra-59	48	42	serum	serum	NOUN
gra-59	48	43	triglycerides	triglyceride	NOUN
gra-59	48	44	are	be	AUX
gra-59	48	45	hydrolyzed	hydrolyze	VERB
gra-59	48	46	to	to	ADP
gra-59	48	47	glycerol	glycerol	NOUN
gra-59	48	48	and	and	CCONJ
gra-59	48	49	free	free	ADJ
gra-59	48	50	fatty	fatty	NOUN
gra-59	48	51	acids	acid	NOUN
gra-59	48	52	by	by	ADP
gra-59	48	53	lipase.in	lipase.in	X
gra-59	48	54	the	the	DET
gra-59	48	55	presence	presence	NOUN
gra-59	48	56	of	of	ADP
gra-59	48	57	atp	atp	PROPN
gra-59	48	58	and	and	CCONJ
gra-59	48	59	glycerol	glycerol	PROPN
gra-59	48	60	kinase	kinase	PROPN
gra-59	48	61	(	(	PUNCT
gra-59	48	62	gk	gk	PROPN
gra-59	48	63	)	)	PUNCT
gra-59	48	64	,	,	PUNCT
gra-59	48	65	the	the	DET
gra-59	48	66	glycerol	glycerol	NOUN
gra-59	48	67	is	be	AUX
gra-59	48	68	converted	convert	VERB
gra-59	48	69	to	to	ADP
gra-59	48	70	glycerol-1	glycerol-1	NOUN
gra-59	48	71	-	-	NOUN
gra-59	48	72	phosphate	phosphate	NOUN
gra-59	48	73	.	.	PUNCT
gra-59	49	1	the	the	DET
gra-59	49	2	glycerol-1	glycerol-1	NUM
gra-59	49	3	-	-	NOUN
gra-59	49	4	phosphate	phosphate	NOUN
gra-59	49	5	is	be	AUX
gra-59	49	6	then	then	ADV
gra-59	49	7	oxidized	oxidize	VERB
gra-59	49	8	by	by	ADP
gra-59	49	9	glycerol	glycerol	NOUN
gra-59	49	10	phosphate	phosphate	NOUN
gra-59	49	11	oxidase	oxidase	NOUN
gra-59	49	12	(	(	PUNCT
gra-59	49	13	gpo	gpo	NOUN
gra-59	49	14	)	)	PUNCT
gra-59	49	15	to	to	PART
gra-59	49	16	yield	yield	VERB
gra-59	49	17	hydrogen	hydrogen	NOUN
gra-59	49	18	peroxide	peroxide	NOUN
gra-59	49	19	.	.	PUNCT
gra-59	50	1	the	the	DET
gra-59	50	2	condensation	condensation	NOUN
gra-59	50	3	of	of	ADP
gra-59	50	4	hydrogen	hydrogen	NOUN
gra-59	50	5	peroxide	peroxide	NOUN
gra-59	50	6	with	with	ADP
gra-59	50	7	4	4	NUM
gra-59	50	8	-	-	PUNCT
gra-59	50	9	chlorophenol	chlorophenol	NOUN
gra-59	50	10	and	and	CCONJ
gra-59	50	11	4aminophenazone	4aminophenazone	NUM
gra-59	50	12	(	(	PUNCT
gra-59	50	13	4	4	NUM
gra-59	50	14	-	-	PUNCT
gra-59	50	15	aa	aa	NOUN
gra-59	50	16	)	)	PUNCT
gra-59	50	17	in	in	ADP
gra-59	50	18	the	the	DET
gra-59	50	19	presence	presence	NOUN
gra-59	50	20	of	of	ADP
gra-59	50	21	peroxidase	peroxidase	NOUN
gra-59	50	22	(	(	PUNCT
gra-59	50	23	pod	pod	NOUN
gra-59	50	24	)	)	PUNCT
gra-59	50	25	produces	produce	VERB
gra-59	50	26	a	a	DET
gra-59	50	27	red	red	ADJ
gra-59	50	28	colored	color	VERB
gra-59	50	29	quinonimine	quinonimine	NOUN
gra-59	50	30	dye	dye	NOUN
gra-59	50	31	which	which	PRON
gra-59	50	32	absorbs	absorb	VERB
gra-59	50	33	at	at	ADP
gra-59	50	34	,	,	PUNCT
gra-59	50	35	or	or	CCONJ
gra-59	50	36	near	near	ADP
gra-59	50	37	500	500	NUM
gra-59	50	38	nm	nm	NOUN
gra-59	50	39	.	.	PUNCT
gra-59	51	1	the	the	DET
gra-59	51	2	intensity	intensity	NOUN
gra-59	51	3	of	of	ADP
gra-59	51	4	the	the	DET
gra-59	51	5	colored	colored	ADJ
gra-59	51	6	complex	complex	NOUN
gra-59	51	7	formed	form	VERB
gra-59	51	8	is	be	AUX
gra-59	51	9	directly	directly	ADV
gra-59	51	10	proportional	proportional	ADJ
gra-59	51	11	to	to	ADP
gra-59	51	12	the	the	DET
gra-59	51	13	triglycerides	triglyceride	NOUN
gra-59	51	14	concentration	concentration	NOUN
gra-59	51	15	of	of	ADP
gra-59	51	16	the	the	DET
gra-59	51	17	sample	sample	NOUN
gra-59	51	18	.	.	PUNCT
gra-59	52	1	calculation	calculation	NOUN
gra-59	52	2	:	:	PUNCT
gra-59	52	3	expected	expect	VERB
gra-59	52	4	values	value	NOUN
gra-59	52	5	:	:	PUNCT
gra-59	52	6	triglycerides	triglyceride	NOUN
gra-59	52	7	normal	normal	ADJ
gra-59	52	8	:	:	PUNCT
gra-59	52	9	<	<	X
gra-59	52	10	150	150	NUM
gra-59	52	11	mg	mg	PROPN
gra-59	52	12	/	/	SYM
gra-59	52	13	dl	dl	PROPN
gra-59	52	14	borderline	borderline	NOUN
gra-59	52	15	high	high	NOUN
gra-59	52	16	:	:	PUNCT
gra-59	52	17	150	150	NUM
gra-59	52	18	-	-	SYM
gra-59	52	19	199	199	NUM
gra-59	52	20	mg	mg	PROPN
gra-59	52	21	/	/	SYM
gra-59	52	22	dl	dl	PROPN
gra-59	52	23	high:≥	high:≥	ADV
gra-59	52	24	200	200	NUM
gra-59	52	25	mg	mg	PROPN
gra-59	52	26	/	/	SYM
gra-59	52	27	dl	dl	PROPN
gra-59	52	28	ÿ	ÿ	DET
gra-59	52	29	estimation	estimation	NOUN
gra-59	52	30	of	of	ADP
gra-59	52	31	serum	serum	NOUN
gra-59	52	32	vldl	vldl	NOUN
gra-59	52	33	-	-	PUNCT
gra-59	52	34	cholesterol	cholesterol	NOUN
gra-59	52	35	and	and	CCONJ
gra-59	52	36	ldlcholesterol	ldlcholesterol	NOUN
gra-59	52	37	:	:	PUNCT
gra-59	52	38	ÿ	ÿ	PROPN
gra-59	52	39	ÿ	ÿ	DET
gra-59	52	40	vldl	vldl	PROPN
gra-59	52	41	was	be	AUX
gra-59	52	42	estimated	estimate	VERB
gra-59	52	43	by	by	ADP
gra-59	52	44	tg/5	tg/5	PROPN
gra-59	52	45	based	base	VERB
gra-59	52	46	on	on	ADP
gra-59	52	47	the	the	DET
gra-59	52	48	average	average	ADJ
gra-59	52	49	ratio	ratio	NOUN
gra-59	52	50	to	to	ADP
gra-59	52	51	cholesterol	cholesterol	NOUN
gra-59	52	52	in	in	ADP
gra-59	52	53	vldl	vldl	PROPN
gra-59	52	54	ÿ	ÿ	SCONJ
gra-59	52	55	serum	serum	PROPN
gra-59	52	56	ldl	ldl	NOUN
gra-59	52	57	was	be	AUX
gra-59	52	58	estimated	estimate	VERB
gra-59	52	59	from	from	ADP
gra-59	52	60	the	the	DET
gra-59	52	61	freidwald	freidwald	NOUN
gra-59	52	62	and	and	CCONJ
gra-59	52	63	fredrickson	fredrickson	PROPN
gra-59	52	64	’s	’s	PART
gra-59	52	65	(	(	PUNCT
gra-59	52	66	1972	1972	NUM
gra-59	52	67	)	)	PUNCT
gra-59	52	68	formula	formula	NOUN
gra-59	52	69	,	,	PUNCT
gra-59	52	70	which	which	PRON
gra-59	52	71	is	be	AUX
gra-59	52	72	ldl	ldl	ADJ
gra-59	52	73	=	=	NOUN
gra-59	52	74	total	total	ADJ
gra-59	52	75	cholesterol-[hdl+vldl	cholesterol-[hdl+vldl	NOUN
gra-59	52	76	]	]	PUNCT
gra-59	53	1	expected	expect	VERB
gra-59	53	2	values	value	NOUN
gra-59	53	3	:	:	PUNCT
gra-59	53	4	ÿ	ÿ	PRON
gra-59	53	5	best	good	ADJ
gra-59	53	6	:	:	PUNCT
gra-59	53	7	less	less	ADJ
gra-59	53	8	than	than	ADP
gra-59	53	9	100	100	NUM
gra-59	53	10	mg	mg	PROPN
gra-59	53	11	/	/	SYM
gra-59	53	12	dl	dl	PROPN
gra-59	53	13	(	(	PUNCT
gra-59	53	14	less	less	ADJ
gra-59	53	15	than	than	ADP
gra-59	53	16	70	70	NUM
gra-59	53	17	mg	mg	PROPN
gra-59	53	18	/	/	SYM
gra-59	53	19	dl	dl	PROPN
gra-59	53	20	for	for	ADP
gra-59	53	21	persons	person	NOUN
gra-59	53	22	with	with	ADP
gra-59	53	23	a	a	DET
gra-59	53	24	history	history	NOUN
gra-59	53	25	of	of	ADP
gra-59	53	26	heart	heart	NOUN
gra-59	53	27	disease	disease	NOUN
gra-59	53	28	or	or	CCONJ
gra-59	53	29	those	those	PRON
gra-59	53	30	at	at	ADP
gra-59	53	31	very	very	ADV
gra-59	53	32	high	high	ADJ
gra-59	53	33	risk	risk	NOUN
gra-59	53	34	)	)	PUNCT
gra-59	53	35	ÿ	ÿ	PROPN
gra-59	53	36	near	near	ADV
gra-59	53	37	best	well	ADV
gra-59	53	38	:	:	PUNCT
gra-59	53	39	100	100	NUM
gra-59	53	40	129	129	NUM
gra-59	53	41	mg	mg	PROPN
gra-59	53	42	/	/	SYM
gra-59	53	43	dl	dl	PROPN
gra-59	53	44	ÿ	ÿ	PROPN
gra-59	53	45	borderline	borderline	NOUN
gra-59	53	46	high	high	ADJ
gra-59	53	47	:	:	PUNCT
gra-59	53	48	130	130	NUM
gra-59	53	49	159	159	NUM
gra-59	53	50	mg	mg	PROPN
gra-59	53	51	/	/	SYM
gra-59	53	52	dl	dl	PROPN
gra-59	53	53	ÿ	ÿ	PROPN
gra-59	53	54	high	high	ADJ
gra-59	53	55	:	:	PUNCT
gra-59	53	56	160	160	NUM
gra-59	53	57	189	189	NUM
gra-59	53	58	mg	mg	NUM
gra-59	53	59	/	/	SYM
gra-59	53	60	dl	dl	PROPN
gra-59	53	61	ÿ	ÿ	PRON
gra-59	53	62	very	very	ADV
gra-59	53	63	high	high	ADJ
gra-59	53	64	:	:	PUNCT
gra-59	53	65	190	190	NUM
gra-59	53	66	mg	mg	PROPN
gra-59	53	67	/	/	SYM
gra-59	53	68	dl	dl	PROPN
gra-59	53	69	and	and	CCONJ
gra-59	53	70	higher	high	ADJ
gra-59	53	71	observation	observation	NOUN
gra-59	53	72	:	:	PUNCT
gra-59	53	73	*	*	PUNCT
gra-59	53	74	values	value	NOUN
gra-59	53	75	presented	present	VERB
gra-59	53	76	as	as	ADP
gra-59	53	77	mean±	mean±	NOUN
gra-59	53	78	sd	sd	ADP
gra-59	53	79	this	this	DET
gra-59	53	80	table	table	NOUN
gra-59	53	81	shows	show	VERB
gra-59	53	82	the	the	DET
gra-59	53	83	level	level	NOUN
gra-59	53	84	of	of	ADP
gra-59	53	85	s.	s.	PROPN
gra-59	53	86	triglyceride	triglyceride	ADP
gra-59	53	87	level	level	NOUN
gra-59	53	88	in	in	ADP
gra-59	53	89	breast	breast	NOUN
gra-59	53	90	cancer	cancer	NOUN
gra-59	53	91	patients	patient	NOUN
gra-59	53	92	and	and	CCONJ
gra-59	53	93	control	control	NOUN
gra-59	53	94	group	group	NOUN
gra-59	53	95	of	of	ADP
gra-59	53	96	156	156	NUM
gra-59	53	97	individual	individual	NOUN
gra-59	53	98	each	each	PRON
gra-59	53	99	are	be	AUX
gra-59	53	100	202.74±53.45	202.74±53.45	NUM
gra-59	53	101	mg	mg	PROPN
gra-59	53	102	/	/	SYM
gra-59	53	103	dl	dl	PROPN
gra-59	53	104	and	and	CCONJ
gra-59	53	105	178.77±99.36	178.77±99.36	NUM
gra-59	53	106	mg	mg	PROPN
gra-59	53	107	/	/	SYM
gra-59	53	108	dl	dl	PROPN
gra-59	53	109	respectively	respectively	ADV
gra-59	53	110	.	.	PUNCT
gra-59	54	1	value	value	NOUN
gra-59	54	2	presented	present	VERB
gra-59	54	3	as	as	ADP
gra-59	54	4	mean	mean	PROPN
gra-59	54	5	±sd	±sd	NOUN
gra-59	54	6	.	.	PUNCT
gra-59	55	1	the	the	DET
gra-59	55	2	value	value	NOUN
gra-59	55	3	of	of	ADP
gra-59	55	4	t	t	NOUN
gra-59	55	5	-	-	PUNCT
gra-59	55	6	value	value	NOUN
gra-59	55	7	and	and	CCONJ
gra-59	55	8	pvalue	pvalue	NOUN
gra-59	55	9	are	be	AUX
gra-59	55	10	2.654	2.654	NUM
gra-59	55	11	and	and	CCONJ
gra-59	55	12	0.008	0.008	NUM
gra-59	55	13	respectively	respectively	ADV
gra-59	55	14	.	.	PUNCT
gra-59	56	1	figure	figure	NOUN
gra-59	56	2	1	1	NUM
gra-59	56	3	:	:	PUNCT
gra-59	56	4	comparison	comparison	NOUN
gra-59	56	5	of	of	ADP
gra-59	56	6	s.	s.	PROPN
gra-59	56	7	triglyceride	triglyceride	PROPN
gra-59	56	8	levels	level	NOUN
gra-59	56	9	in	in	ADP
gra-59	56	10	the	the	DET
gra-59	56	11	study	study	NOUN
gra-59	56	12	groups	group	NOUN
gra-59	56	13	this	this	DET
gra-59	56	14	gure	gure	NOUN
gra-59	56	15	shows	show	VERB
gra-59	56	16	the	the	DET
gra-59	56	17	comparison	comparison	NOUN
gra-59	56	18	graph	graph	NOUN
gra-59	56	19	between	between	ADP
gra-59	56	20	mean	mean	VERB
gra-59	56	21	serum	serum	NOUN
gra-59	56	22	triglycerides	triglyceride	NOUN
gra-59	56	23	level	level	NOUN
gra-59	56	24	in	in	ADP
gra-59	56	25	breast	breast	NOUN
gra-59	56	26	cancer	cancer	NOUN
gra-59	56	27	patients	patient	NOUN
gra-59	56	28	&	&	CCONJ
gra-59	56	29	control	control	PROPN
gra-59	56	30	group	group	PROPN
gra-59	56	31	are	be	AUX
gra-59	56	32	202.74	202.74	NUM
gra-59	56	33	mg	mg	PROPN
gra-59	56	34	/	/	SYM
gra-59	56	35	dl	dl	PROPN
gra-59	56	36	and	and	CCONJ
gra-59	56	37	178.77mg	178.77mg	NUM
gra-59	56	38	/	/	SYM
gra-59	56	39	dl	dl	PROPN
gra-59	56	40	respectively	respectively	ADV
gra-59	56	41	whereas	whereas	SCONJ
gra-59	56	42	sd	sd	NOUN
gra-59	56	43	in	in	ADP
gra-59	56	44	breast	breast	NOUN
gra-59	56	45	cancer	cancer	NOUN
gra-59	56	46	group	group	NOUN
gra-59	56	47	and	and	CCONJ
gra-59	56	48	control	control	NOUN
gra-59	56	49	group	group	NOUN
gra-59	56	50	are	be	AUX
gra-59	56	51	53.45mg	53.45mg	NUM
gra-59	56	52	/	/	SYM
gra-59	56	53	dl	dl	PROPN
gra-59	56	54	and	and	CCONJ
gra-59	56	55	99.36mg	99.36mg	X
gra-59	56	56	/	/	SYM
gra-59	56	57	dl	dl	X
gra-59	56	58	respectively	respectively	ADV
gra-59	56	59	.	.	PUNCT
gra-59	57	1	table	table	NOUN
gra-59	57	2	2	2	NUM
gra-59	57	3	:	:	PUNCT
gra-59	57	4	comparison	comparison	NOUN
gra-59	57	5	of	of	ADP
gra-59	57	6	s.	s.	PROPN
gra-59	57	7	cholesterol	cholesterol	PROPN
gra-59	57	8	levels	level	NOUN
gra-59	57	9	in	in	ADP
gra-59	57	10	the	the	DET
gra-59	57	11	study	study	NOUN
gra-59	57	12	groups	group	NOUN
gra-59	57	13	volume-8	volume-8	NUM
gra-59	57	14	,	,	PUNCT
gra-59	57	15	issue-9	issue-9	NUM
gra-59	57	16	,	,	PUNCT
gra-59	57	17	september-2019	september-2019	ADJ
gra-59	57	18	•	•	NUM
gra-59	57	19	print	print	NOUN
gra-59	57	20	issn	issn	PROPN
gra-59	57	21	no	no	NOUN
gra-59	57	22	.	.	PROPN
gra-59	57	23	2277	2277	NUM
gra-59	57	24	8160	8160	NUM
gra-59	57	25	•	•	NOUN
gra-59	57	26	doi	doi	NOUN
gra-59	57	27	:	:	PUNCT
gra-59	57	28	10.36106	10.36106	NUM
gra-59	57	29	/	/	SYM
gra-59	57	30	gjra	gjra	NOUN
gra-59	57	31	groups	group	NOUN
gra-59	57	32	no	no	INTJ
gra-59	57	33	.	.	PUNCT
gra-59	57	34	of	of	ADP
gra-59	57	35	cases	case	NOUN
gra-59	57	36	(	(	PUNCT
gra-59	57	37	n	n	CCONJ
gra-59	57	38	)	)	PUNCT
gra-59	58	1	s.	s.	PROPN
gra-59	58	2	tg	tg	PROPN
gra-59	58	3	(	(	PUNCT
gra-59	58	4	mg	mg	PROPN
gra-59	58	5	/	/	SYM
gra-59	58	6	dl	dl	PROPN
gra-59	58	7	)	)	PUNCT
gra-59	58	8	t	t	NOUN
gra-59	58	9	-	-	PUNCT
gra-59	58	10	value	value	NOUN
gra-59	58	11	p	p	NOUN
gra-59	58	12	-	-	PUNCT
gra-59	58	13	value	value	NOUN
gra-59	58	14	breast	breast	NOUN
gra-59	58	15	cancer	cancer	NOUN
gra-59	58	16	patients	patient	NOUN
gra-59	58	17	156	156	NUM
gra-59	58	18	202.74	202.74	NUM
gra-59	58	19	±	±	NOUN
gra-59	58	20	53.45	53.45	NUM
gra-59	58	21	2.654	2.654	NUM
gra-59	58	22	0.008	0.008	NUM
gra-59	58	23	control	control	NOUN
gra-59	58	24	156	156	NUM
gra-59	58	25	178.77	178.77	NUM
gra-59	58	26	±	±	NUM
gra-59	58	27	99.36	99.36	NUM
gra-59	58	28	groups	group	NOUN
gra-59	58	29	no	no	INTJ
gra-59	58	30	.	.	NOUN
gra-59	59	1	of	of	ADP
gra-59	59	2	cases	case	NOUN
gra-59	59	3	(	(	PUNCT
gra-59	59	4	n	n	CCONJ
gra-59	59	5	)	)	PUNCT
gra-59	59	6	s.	s.	PROPN
gra-59	59	7	cholesterol	cholesterol	PROPN
gra-59	59	8	(	(	PUNCT
gra-59	59	9	mg	mg	PROPN
gra-59	59	10	/	/	SYM
gra-59	59	11	dl	dl	PROPN
gra-59	59	12	)	)	PUNCT
gra-59	59	13	t	t	NOUN
gra-59	59	14	-	-	PUNCT
gra-59	59	15	value	value	NOUN
gra-59	59	16	p	p	NOUN
gra-59	59	17	-	-	PUNCT
gra-59	59	18	value	value	NOUN
gra-59	59	19	breast	breast	NOUN
gra-59	59	20	cancer	cancer	NOUN
gra-59	59	21	patients	patient	NOUN
gra-59	59	22	156	156	NUM
gra-59	59	23	205.62	205.62	NUM
gra-59	59	24	±	±	NOUN
gra-59	59	25	46.09	46.09	NUM
gra-59	59	26	9.439	9.439	NUM
gra-59	59	27	0.000	0.000	NUM
gra-59	59	28	control	control	NOUN
gra-59	59	29	156	156	NUM
gra-59	59	30	158.73	158.73	NUM
gra-59	59	31	±	±	NOUN
gra-59	59	32	41.59	41.59	NUM
gra-59	59	33	*	*	PUNCT
gra-59	59	34	values	value	NOUN
gra-59	59	35	presented	present	VERB
gra-59	59	36	as	as	ADP
gra-59	59	37	mean±	mean±	NOUN
gra-59	59	38	sd	sd	ADP
gra-59	59	39	this	this	DET
gra-59	59	40	table	table	NOUN
gra-59	59	41	shows	show	VERB
gra-59	59	42	the	the	DET
gra-59	59	43	level	level	NOUN
gra-59	59	44	of	of	ADP
gra-59	59	45	s.	s.	PROPN
gra-59	59	46	cholersyerol	cholersyerol	PROPN
gra-59	59	47	level	level	NOUN
gra-59	59	48	in	in	ADP
gra-59	59	49	breast	breast	NOUN
gra-59	59	50	cancer	cancer	NOUN
gra-59	59	51	patients	patient	NOUN
gra-59	59	52	and	and	CCONJ
gra-59	59	53	control	control	NOUN
gra-59	59	54	group	group	NOUN
gra-59	59	55	of	of	ADP
gra-59	59	56	156	156	NUM
gra-59	59	57	individual	individual	NOUN
gra-59	59	58	each	each	PRON
gra-59	59	59	are	be	AUX
gra-59	59	60	205.62±46.09	205.62±46.09	NUM
gra-59	59	61	mg	mg	PROPN
gra-59	59	62	/	/	SYM
gra-59	59	63	dl	dl	PROPN
gra-59	59	64	and	and	CCONJ
gra-59	59	65	158.73±41.59	158.73±41.59	NUM
gra-59	59	66	mg	mg	PROPN
gra-59	59	67	/	/	SYM
gra-59	59	68	dl	dl	PROPN
gra-59	59	69	respectively	respectively	ADV
gra-59	59	70	.	.	PUNCT
gra-59	60	1	value	value	NOUN
gra-59	60	2	presented	present	VERB
gra-59	60	3	as	as	ADP
gra-59	60	4	mean	mean	PROPN
gra-59	60	5	±sd	±sd	NOUN
gra-59	60	6	.	.	PUNCT
gra-59	61	1	the	the	DET
gra-59	61	2	value	value	NOUN
gra-59	61	3	of	of	ADP
gra-59	61	4	t	t	NOUN
gra-59	61	5	-	-	PUNCT
gra-59	61	6	value	value	NOUN
gra-59	61	7	and	and	CCONJ
gra-59	61	8	pvalue	pvalue	NOUN
gra-59	61	9	are	be	AUX
gra-59	61	10	9.439	9.439	NUM
gra-59	61	11	and	and	CCONJ
gra-59	61	12	0.000	0.000	NUM
gra-59	61	13	respectively	respectively	ADV
gra-59	61	14	figure	figure	NOUN
gra-59	61	15	2	2	NUM
gra-59	61	16	:	:	PUNCT
gra-59	61	17	comparison	comparison	NOUN
gra-59	61	18	of	of	ADP
gra-59	61	19	serum	serum	NOUN
gra-59	61	20	cholesterol	cholesterol	NOUN
gra-59	61	21	levels	level	NOUN
gra-59	61	22	in	in	ADP
gra-59	61	23	study	study	NOUN
gra-59	61	24	groups	group	NOUN
gra-59	61	25	this	this	DET
gra-59	61	26	gure	gure	NOUN
gra-59	61	27	shows	show	VERB
gra-59	61	28	the	the	DET
gra-59	61	29	comparison	comparison	NOUN
gra-59	61	30	graph	graph	NOUN
gra-59	61	31	between	between	ADP
gra-59	61	32	mean	mean	PROPN
gra-59	61	33	serum	serum	NOUN
gra-59	61	34	cholesterol	cholesterol	NOUN
gra-59	61	35	level	level	NOUN
gra-59	61	36	in	in	ADP
gra-59	61	37	breast	breast	NOUN
gra-59	61	38	cancer	cancer	NOUN
gra-59	61	39	patients	patient	NOUN
gra-59	61	40	&	&	CCONJ
gra-59	61	41	control	control	PROPN
gra-59	61	42	group	group	PROPN
gra-59	61	43	are	be	AUX
gra-59	61	44	205.62	205.62	NUM
gra-59	61	45	mg	mg	PROPN
gra-59	61	46	/	/	SYM
gra-59	61	47	dl	dl	PROPN
gra-59	61	48	and	and	CCONJ
gra-59	61	49	158.73mg	158.73mg	NUM
gra-59	61	50	/	/	SYM
gra-59	61	51	dl	dl	PROPN
gra-59	61	52	respectively	respectively	ADV
gra-59	61	53	whereas	whereas	SCONJ
gra-59	61	54	sd	sd	NOUN
gra-59	61	55	in	in	ADP
gra-59	61	56	breast	breast	NOUN
gra-59	61	57	cancer	cancer	NOUN
gra-59	61	58	group	group	NOUN
gra-59	61	59	and	and	CCONJ
gra-59	61	60	control	control	NOUN
gra-59	61	61	group	group	NOUN
gra-59	61	62	are	be	AUX
gra-59	61	63	46.09mg	46.09mg	NUM
gra-59	61	64	/	/	SYM
gra-59	61	65	dl	dl	PROPN
gra-59	61	66	and	and	CCONJ
gra-59	61	67	41.59mg	41.59mg	NUM
gra-59	61	68	/	/	SYM
gra-59	61	69	dl	dl	PROPN
gra-59	61	70	respectively	respectively	ADV
gra-59	61	71	.	.	PUNCT
gra-59	62	1	table	table	NOUN
gra-59	62	2	3	3	NUM
gra-59	62	3	:	:	PUNCT
gra-59	62	4	comparison	comparison	NOUN
gra-59	62	5	of	of	ADP
gra-59	62	6	s.	s.	PROPN
gra-59	62	7	hdl	hdl	PROPN
gra-59	62	8	-	-	PUNCT
gra-59	62	9	chol	chol	NOUN
gra-59	62	10	levels	level	NOUN
gra-59	62	11	in	in	ADP
gra-59	62	12	the	the	DET
gra-59	62	13	study	study	NOUN
gra-59	62	14	groups	group	NOUN
gra-59	62	15	*	*	VERB
gra-59	62	16	values	value	NOUN
gra-59	62	17	presented	present	VERB
gra-59	62	18	as	as	ADP
gra-59	62	19	mean±	mean±	NOUN
gra-59	62	20	sd	sd	ADP
gra-59	62	21	this	this	DET
gra-59	62	22	table	table	NOUN
gra-59	62	23	shows	show	VERB
gra-59	62	24	the	the	DET
gra-59	62	25	level	level	NOUN
gra-59	62	26	of	of	ADP
gra-59	62	27	s.	s.	PROPN
gra-59	62	28	hdl	hdl	PROPN
gra-59	62	29	-	-	PUNCT
gra-59	62	30	cholesterol	cholesterol	NOUN
gra-59	62	31	level	level	NOUN
gra-59	62	32	in	in	ADP
gra-59	62	33	breast	breast	NOUN
gra-59	62	34	cancer	cancer	NOUN
gra-59	62	35	patients	patient	NOUN
gra-59	62	36	and	and	CCONJ
gra-59	62	37	control	control	NOUN
gra-59	62	38	group	group	NOUN
gra-59	62	39	of	of	ADP
gra-59	62	40	156	156	NUM
gra-59	62	41	individual	individual	NOUN
gra-59	62	42	each	each	PRON
gra-59	62	43	are	be	AUX
gra-59	62	44	39.20±5.30	39.20±5.30	NUM
gra-59	62	45	mg	mg	PROPN
gra-59	62	46	/	/	SYM
gra-59	62	47	dl	dl	PROPN
gra-59	62	48	and	and	CCONJ
gra-59	62	49	40.46±8.96	40.46±8.96	NUM
gra-59	62	50	mg	mg	PROPN
gra-59	62	51	/	/	SYM
gra-59	62	52	dl	dl	PROPN
gra-59	62	53	respectively	respectively	ADV
gra-59	62	54	.	.	PUNCT
gra-59	63	1	value	value	NOUN
gra-59	63	2	presented	present	VERB
gra-59	63	3	as	as	ADP
gra-59	63	4	mean	mean	PROPN
gra-59	63	5	±sd	±sd	NOUN
gra-59	63	6	.	.	PUNCT
gra-59	64	1	the	the	DET
gra-59	64	2	value	value	NOUN
gra-59	64	3	of	of	ADP
gra-59	64	4	t	t	NOUN
gra-59	64	5	-	-	PUNCT
gra-59	64	6	value	value	NOUN
gra-59	64	7	and	and	CCONJ
gra-59	64	8	pvalue	pvalue	NOUN
gra-59	64	9	are	be	AUX
gra-59	64	10	-1.512	-1.512	NUM
gra-59	64	11	and	and	CCONJ
gra-59	64	12	ns	ns	ADJ
gra-59	64	13	respectively	respectively	ADV
gra-59	64	14	figure	figure	NOUN
gra-59	64	15	3	3	NUM
gra-59	64	16	:	:	PUNCT
gra-59	64	17	comparison	comparison	NOUN
gra-59	64	18	of	of	ADP
gra-59	64	19	s.	s.	PROPN
gra-59	64	20	hdl	hdl	PROPN
gra-59	64	21	-	-	PUNCT
gra-59	64	22	chol	chol	NOUN
gra-59	64	23	levels	level	NOUN
gra-59	64	24	in	in	ADP
gra-59	64	25	the	the	DET
gra-59	64	26	study	study	NOUN
gra-59	64	27	groups	group	NOUN
gra-59	64	28	this	this	DET
gra-59	64	29	gure	gure	NOUN
gra-59	64	30	shows	show	VERB
gra-59	64	31	the	the	DET
gra-59	64	32	comparison	comparison	NOUN
gra-59	64	33	graph	graph	NOUN
gra-59	64	34	between	between	ADP
gra-59	64	35	mean	mean	PROPN
gra-59	64	36	serum	serum	PROPN
gra-59	64	37	hdl	hdl	PROPN
gra-59	64	38	-	-	PUNCT
gra-59	64	39	cholesterol	cholesterol	NOUN
gra-59	64	40	level	level	NOUN
gra-59	64	41	in	in	ADP
gra-59	64	42	breast	breast	NOUN
gra-59	64	43	cancer	cancer	NOUN
gra-59	64	44	patients	patient	NOUN
gra-59	64	45	&	&	CCONJ
gra-59	64	46	control	control	PROPN
gra-59	64	47	group	group	PROPN
gra-59	64	48	are	be	AUX
gra-59	64	49	39.2	39.2	NUM
gra-59	64	50	mg	mg	PROPN
gra-59	64	51	/	/	SYM
gra-59	64	52	dl	dl	PROPN
gra-59	64	53	and	and	CCONJ
gra-59	64	54	40.46mg	40.46mg	NUM
gra-59	64	55	/	/	SYM
gra-59	64	56	dl	dl	NOUN
gra-59	64	57	respectively	respectively	ADV
gra-59	64	58	whereas	whereas	SCONJ
gra-59	64	59	sd	sd	NOUN
gra-59	64	60	in	in	ADP
gra-59	64	61	breast	breast	NOUN
gra-59	64	62	cancer	cancer	NOUN
gra-59	64	63	group	group	NOUN
gra-59	64	64	and	and	CCONJ
gra-59	64	65	control	control	NOUN
gra-59	64	66	group	group	NOUN
gra-59	64	67	are	be	AUX
gra-59	64	68	5.3mg	5.3mg	NUM
gra-59	64	69	/	/	SYM
gra-59	64	70	dl	dl	PROPN
gra-59	64	71	and	and	CCONJ
gra-59	64	72	8.96mg	8.96mg	NUM
gra-59	64	73	/	/	SYM
gra-59	64	74	dl	dl	PROPN
gra-59	64	75	respectively	respectively	ADV
gra-59	64	76	.	.	PUNCT
gra-59	65	1	*	*	PUNCT
gra-59	65	2	values	value	NOUN
gra-59	65	3	presented	present	VERB
gra-59	65	4	as	as	ADP
gra-59	65	5	mean±	mean±	NOUN
gra-59	65	6	sd	sd	ADP
gra-59	65	7	this	this	DET
gra-59	65	8	table	table	NOUN
gra-59	65	9	shows	show	VERB
gra-59	65	10	the	the	DET
gra-59	65	11	level	level	NOUN
gra-59	65	12	of	of	ADP
gra-59	65	13	s.	s.	PROPN
gra-59	65	14	ldl	ldl	PROPN
gra-59	65	15	level	level	NOUN
gra-59	65	16	in	in	ADP
gra-59	65	17	breast	breast	NOUN
gra-59	65	18	cancer	cancer	NOUN
gra-59	65	19	patients	patient	NOUN
gra-59	65	20	and	and	CCONJ
gra-59	65	21	control	control	NOUN
gra-59	65	22	group	group	NOUN
gra-59	65	23	of	of	ADP
gra-59	65	24	156	156	NUM
gra-59	65	25	individual	individual	NOUN
gra-59	65	26	each	each	PRON
gra-59	65	27	are	be	AUX
gra-59	65	28	125.87±	125.87±	NUM
gra-59	65	29	46.97mg	46.97mg	NUM
gra-59	65	30	/	/	SYM
gra-59	65	31	dl	dl	PROPN
gra-59	65	32	and	and	CCONJ
gra-59	65	33	81.54±29.21	81.54±29.21	NUM
gra-59	65	34	mg	mg	PROPN
gra-59	65	35	/	/	SYM
gra-59	65	36	dl	dl	PROPN
gra-59	65	37	respectively	respectively	ADV
gra-59	65	38	.	.	PUNCT
gra-59	66	1	value	value	NOUN
gra-59	66	2	presented	present	VERB
gra-59	66	3	as	as	ADP
gra-59	66	4	mean	mean	PROPN
gra-59	66	5	±sd	±sd	NOUN
gra-59	66	6	.	.	PUNCT
gra-59	67	1	the	the	DET
gra-59	67	2	value	value	NOUN
gra-59	67	3	of	of	ADP
gra-59	67	4	t	t	NOUN
gra-59	67	5	-	-	PUNCT
gra-59	67	6	value	value	NOUN
gra-59	67	7	and	and	CCONJ
gra-59	67	8	p	p	NOUN
gra-59	67	9	-	-	PUNCT
gra-59	67	10	value	value	NOUN
gra-59	67	11	are	be	AUX
gra-59	67	12	10.010	10.010	NUM
gra-59	67	13	and	and	CCONJ
gra-59	67	14	0.000	0.000	NUM
gra-59	67	15	respectively	respectively	ADV
gra-59	67	16	figure	figure	NOUN
gra-59	67	17	4	4	NUM
gra-59	67	18	:	:	PUNCT
gra-59	67	19	comparison	comparison	NOUN
gra-59	67	20	of	of	ADP
gra-59	67	21	s.	s.	PROPN
gra-59	67	22	ldl	ldl	PROPN
gra-59	67	23	levels	level	NOUN
gra-59	67	24	in	in	ADP
gra-59	67	25	the	the	DET
gra-59	67	26	study	study	NOUN
gra-59	67	27	groups	group	NOUN
gra-59	67	28	this	this	DET
gra-59	67	29	gure	gure	NOUN
gra-59	67	30	shows	show	VERB
gra-59	67	31	the	the	DET
gra-59	67	32	comparison	comparison	NOUN
gra-59	67	33	graph	graph	NOUN
gra-59	67	34	between	between	ADP
gra-59	67	35	mean	mean	VERB
gra-59	67	36	serum	serum	NOUN
gra-59	67	37	ldl	ldl	NOUN
gra-59	67	38	level	level	NOUN
gra-59	67	39	in	in	ADP
gra-59	67	40	breast	breast	NOUN
gra-59	67	41	cancer	cancer	NOUN
gra-59	67	42	patients	patient	NOUN
gra-59	67	43	&	&	CCONJ
gra-59	67	44	control	control	PROPN
gra-59	67	45	group	group	PROPN
gra-59	67	46	are	be	AUX
gra-59	67	47	125.87mg	125.87mg	NUM
gra-59	67	48	/	/	SYM
gra-59	67	49	dl	dl	PROPN
gra-59	67	50	and	and	CCONJ
gra-59	67	51	81.54mg	81.54mg	NUM
gra-59	67	52	/	/	SYM
gra-59	67	53	dl	dl	PROPN
gra-59	67	54	respectively	respectively	ADV
gra-59	67	55	whereas	whereas	SCONJ
gra-59	67	56	sd	sd	NOUN
gra-59	67	57	in	in	ADP
gra-59	67	58	breast	breast	NOUN
gra-59	67	59	cancer	cancer	NOUN
gra-59	67	60	group	group	NOUN
gra-59	67	61	and	and	CCONJ
gra-59	67	62	control	control	NOUN
gra-59	67	63	group	group	NOUN
gra-59	67	64	are	be	AUX
gra-59	67	65	46.97mg	46.97mg	NUM
gra-59	67	66	/	/	SYM
gra-59	67	67	dl	dl	PROPN
gra-59	67	68	and	and	CCONJ
gra-59	67	69	29.21mg	29.21mg	PROPN
gra-59	67	70	/	/	SYM
gra-59	67	71	dl	dl	PROPN
gra-59	67	72	respectively	respectively	ADV
gra-59	67	73	.	.	PUNCT
gra-59	68	1	table	table	NOUN
gra-59	68	2	5	5	NUM
gra-59	68	3	:	:	PUNCT
gra-59	68	4	comparison	comparison	NOUN
gra-59	68	5	of	of	ADP
gra-59	68	6	s.	s.	PROPN
gra-59	68	7	vldl	vldl	PROPN
gra-59	68	8	levels	level	NOUN
gra-59	68	9	in	in	ADP
gra-59	68	10	the	the	DET
gra-59	68	11	study	study	NOUN
gra-59	68	12	groups	group	NOUN
gra-59	68	13	*	*	VERB
gra-59	68	14	values	value	NOUN
gra-59	68	15	presented	present	VERB
gra-59	68	16	as	as	ADP
gra-59	68	17	mean±	mean±	NOUN
gra-59	68	18	sd	sd	ADP
gra-59	68	19	this	this	DET
gra-59	68	20	table	table	NOUN
gra-59	68	21	shows	show	VERB
gra-59	68	22	the	the	DET
gra-59	68	23	level	level	NOUN
gra-59	68	24	of	of	ADP
gra-59	68	25	s.	s.	PROPN
gra-59	68	26	vldl	vldl	PROPN
gra-59	68	27	level	level	NOUN
gra-59	68	28	in	in	ADP
gra-59	68	29	breast	breast	NOUN
gra-59	68	30	cancer	cancer	NOUN
gra-59	68	31	patients	patient	NOUN
gra-59	68	32	and	and	CCONJ
gra-59	68	33	control	control	NOUN
gra-59	68	34	group	group	NOUN
gra-59	68	35	of	of	ADP
gra-59	68	36	156	156	NUM
gra-59	68	37	individual	individual	NOUN
gra-59	68	38	each	each	PRON
gra-59	68	39	are	be	AUX
gra-59	68	40	40.55±	40.55±	NUM
gra-59	68	41	10.69mg	10.69mg	NUM
gra-59	68	42	/	/	SYM
gra-59	68	43	dl	dl	PROPN
gra-59	68	44	and	and	CCONJ
gra-59	68	45	35.70±19.94	35.70±19.94	NUM
gra-59	68	46	mg	mg	PROPN
gra-59	68	47	/	/	SYM
gra-59	68	48	dl	dl	PROPN
gra-59	68	49	respectively	respectively	ADV
gra-59	68	50	.	.	PUNCT
gra-59	69	1	value	value	NOUN
gra-59	69	2	presented	present	VERB
gra-59	69	3	as	as	ADP
gra-59	69	4	mean	mean	PROPN
gra-59	69	5	±sd	±sd	NOUN
gra-59	69	6	.	.	PUNCT
gra-59	70	1	the	the	DET
gra-59	70	2	value	value	NOUN
gra-59	70	3	of	of	ADP
gra-59	70	4	t	t	NOUN
gra-59	70	5	-	-	PUNCT
gra-59	70	6	value	value	NOUN
gra-59	70	7	and	and	CCONJ
gra-59	70	8	p	p	NOUN
gra-59	70	9	-	-	PUNCT
gra-59	70	10	value	value	NOUN
gra-59	70	11	are	be	AUX
gra-59	70	12	2.667	2.667	NUM
gra-59	70	13	and	and	CCONJ
gra-59	70	14	0.008	0.008	NUM
gra-59	70	15	respectively	respectively	ADV
gra-59	70	16	.	.	PUNCT
gra-59	71	1	figure	figure	VERB
gra-59	71	2	5	5	NUM
gra-59	71	3	:	:	PUNCT
gra-59	71	4	comparison	comparison	NOUN
gra-59	71	5	of	of	ADP
gra-59	71	6	s.	s.	PROPN
gra-59	71	7	vldl	vldl	PROPN
gra-59	71	8	levels	level	NOUN
gra-59	71	9	in	in	ADP
gra-59	71	10	the	the	DET
gra-59	71	11	study	study	NOUN
gra-59	71	12	groups	group	NOUN
gra-59	71	13	this	this	DET
gra-59	71	14	gure	gure	NOUN
gra-59	71	15	shows	show	VERB
gra-59	71	16	the	the	DET
gra-59	71	17	comparison	comparison	NOUN
gra-59	71	18	graph	graph	NOUN
gra-59	71	19	between	between	ADP
gra-59	71	20	mean	mean	PROPN
gra-59	71	21	serum	serum	NOUN
gra-59	71	22	vldl	vldl	PROPN
gra-59	71	23	level	level	NOUN
gra-59	71	24	in	in	ADP
gra-59	71	25	breast	breast	NOUN
gra-59	71	26	cancer	cancer	NOUN
gra-59	71	27	patients	patient	NOUN
gra-59	71	28	&	&	CCONJ
gra-59	71	29	control	control	PROPN
gra-59	71	30	group	group	PROPN
gra-59	71	31	are	be	AUX
gra-59	71	32	40.55mg	40.55mg	NUM
gra-59	71	33	/	/	SYM
gra-59	71	34	dl	dl	PROPN
gra-59	71	35	and	and	CCONJ
gra-59	71	36	35.70mg	35.70mg	NUM
gra-59	71	37	/	/	SYM
gra-59	71	38	dl	dl	PROPN
gra-59	71	39	respectively	respectively	ADV
gra-59	71	40	whereas	whereas	SCONJ
gra-59	71	41	sd	sd	NOUN
gra-59	71	42	in	in	ADP
gra-59	71	43	breast	breast	NOUN
gra-59	71	44	cancer	cancer	NOUN
gra-59	71	45	group	group	NOUN
gra-59	71	46	and	and	CCONJ
gra-59	71	47	control	control	NOUN
gra-59	71	48	group	group	NOUN
gra-59	71	49	are	be	AUX
gra-59	71	50	10.69mg	10.69mg	NUM
gra-59	71	51	/	/	SYM
gra-59	71	52	dl	dl	PROPN
gra-59	71	53	and	and	CCONJ
gra-59	71	54	19.94mg	19.94mg	NUM
gra-59	71	55	/	/	SYM
gra-59	71	56	dl	dl	NOUN
gra-59	71	57	respectively	respectively	ADV
gra-59	71	58	.	.	PUNCT
gra-59	72	1	results	result	NOUN
gra-59	72	2	&	&	CCONJ
gra-59	72	3	discussion	discussion	NOUN
gra-59	72	4	:	:	PUNCT
gra-59	72	5	in	in	ADP
gra-59	72	6	this	this	DET
gra-59	72	7	study	study	NOUN
gra-59	72	8	,	,	PUNCT
gra-59	72	9	the	the	DET
gra-59	72	10	mean	mean	ADJ
gra-59	72	11	serum	serum	NOUN
gra-59	72	12	tg	tg	PROPN
gra-59	72	13	level	level	NOUN
gra-59	72	14	in	in	ADP
gra-59	72	15	breast	breast	NOUN
gra-59	72	16	cancer	cancer	NOUN
gra-59	72	17	patients	patient	NOUN
gra-59	72	18	was	be	AUX
gra-59	72	19	202.74±53.45	202.74±53.45	NUM
gra-59	72	20	mg	mg	PROPN
gra-59	72	21	/	/	SYM
gra-59	72	22	dl	dl	PROPN
gra-59	72	23	while	while	SCONJ
gra-59	72	24	in	in	ADP
gra-59	72	25	case	case	NOUN
gra-59	72	26	of	of	ADP
gra-59	72	27	control	control	NOUN
gra-59	72	28	group	group	NOUN
gra-59	72	29	it	it	PRON
gra-59	72	30	's	be	AUX
gra-59	72	31	was	be	AUX
gra-59	72	32	178.77±99.36	178.77±99.36	NUM
gra-59	72	33	mg	mg	PROPN
gra-59	72	34	/	/	SYM
gra-59	72	35	dl.this	dl.thi	NOUN
gra-59	72	36	difference	difference	NOUN
gra-59	72	37	was	be	AUX
gra-59	72	38	statistically	statistically	ADV
gra-59	72	39	signicant	signicant	ADJ
gra-59	72	40	(	(	PUNCT
gra-59	72	41	pvalue=.008	pvalue=.008	NOUN
gra-59	72	42	)	)	PUNCT
gra-59	72	43	.	.	PUNCT
gra-59	73	1	the	the	DET
gra-59	73	2	present	present	ADJ
gra-59	73	3	study	study	NOUN
gra-59	73	4	was	be	AUX
gra-59	73	5	supported	support	VERB
gra-59	73	6	by	by	ADP
gra-59	73	7	some	some	DET
gra-59	73	8	scholars	scholar	NOUN
gra-59	73	9	.	.	PUNCT
gra-59	74	1	according	accord	VERB
gra-59	74	2	to	to	ADP
gra-59	74	3	j.r.peelain	j.r.peelain	PROPN
gra-59	74	4	et	et	PROPN
gra-59	74	5	al4	al4	PROPN
gra-59	74	6	in	in	ADP
gra-59	74	7	2012	2012	NUM
gra-59	74	8	,	,	PUNCT
gra-59	74	9	the	the	DET
gra-59	74	10	tg	tg	PROPN
gra-59	74	11	levels	level	NOUN
gra-59	74	12	were	be	AUX
gra-59	74	13	signicantly	signicantly	ADV
gra-59	74	14	higher	high	ADJ
gra-59	74	15	in	in	ADP
gra-59	74	16	women	woman	NOUN
gra-59	74	17	with	with	ADP
gra-59	74	18	node	node	NOUN
gra-59	74	19	-	-	PUNCT
gra-59	74	20	negative	negative	ADJ
gra-59	74	21	invasive	invasive	ADJ
gra-59	74	22	cancer(0.94+/-1.04mg	cancer(0.94+/-1.04mg	NOUN
gra-59	74	23	/	/	SYM
gra-59	74	24	ml	ml	NOUN
gra-59	74	25	)	)	PUNCT
gra-59	74	26	than	than	ADP
gra-59	74	27	in	in	ADP
gra-59	74	28	t	t	PROPN
gra-59	74	29	h	h	NOUN
gra-59	75	1	o	o	NOUN
gra-59	75	2	s	s	X
gra-59	75	3	e	e	X
gra-59	75	4	w	w	NOUN
gra-59	76	1	i	i	NOUN
gra-59	77	1	t	t	NOUN
gra-59	78	1	h	h	NOUN
gra-59	79	1	n	n	NOUN
gra-59	79	2	o	o	X
gra-59	80	1	e	e	X
gra-59	80	2	p	p	X
gra-59	80	3	i	i	X
gra-59	80	4	t	t	NOUN
gra-59	80	5	h	h	NOUN
gra-59	80	6	e	e	NOUN
gra-59	80	7	l	l	NOUN
gra-59	80	8	i	i	PRON
gra-59	80	9	a	a	DET
gra-59	80	10	l	l	NOUN
gra-59	81	1	p	p	NOUN
gra-59	81	2	r	r	NOUN
gra-59	81	3	o	o	NOUN
gra-59	81	4	l	l	NOUN
gra-59	82	1	i	i	NOUN
gra-59	82	2	f	f	NOUN
gra-59	83	1	e	e	X
gra-59	83	2	r	r	NOUN
gra-59	83	3	a	a	PROPN
gra-59	83	4	t	t	NOUN
gra-59	84	1	i	i	PRON
gra-59	84	2	o	o	VERB
gra-59	84	3	n	n	CCONJ
gra-59	84	4	(	(	PUNCT
gra-59	84	5	0	0	NUM
gra-59	84	6	.	.	NOUN
gra-59	85	1	8	8	NUM
gra-59	85	2	3	3	NUM
gra-59	85	3	+	+	CCONJ
gra-59	85	4	/	/	SYM
gra-59	85	5	1.04mg	1.04mg	NUM
gra-59	85	6	/	/	SYM
gra-59	85	7	ml	ml	NOUN
gra-59	85	8	,	,	PUNCT
gra-59	85	9	p=0.03	p=0.03	ADJ
gra-59	85	10	)	)	PUNCT
gra-59	85	11	.	.	PUNCT
gra-59	86	1	another	another	DET
gra-59	86	2	study	study	NOUN
gra-59	86	3	conducted	conduct	VERB
gra-59	86	4	by	by	ADP
gra-59	86	5	vinayak	vinayak	PROPN
gra-59	86	6	v	v	PROPN
gra-59	86	7	kshirsagar	kshirsagar	NOUN
gra-59	86	8	et	et	NOUN
gra-59	86	9	al5	al5	NOUN
gra-59	86	10	in	in	ADP
gra-59	86	11	2016	2016	NUM
gra-59	86	12	showed	show	VERB
gra-59	86	13	that	that	DET
gra-59	86	14	total	total	NOUN
gra-59	86	15	triglyceride	triglyceride	INTJ
gra-59	86	16	incase	incase	NOUN
gra-59	86	17	of	of	ADP
gra-59	86	18	casesis	casesis	NOUN
gra-59	86	19	135mg	135mg	PROPN
gra-59	86	20	/	/	SYM
gra-59	86	21	dl	dl	PROPN
gra-59	86	22	as	as	SCONJ
gra-59	86	23	compared	compare	VERB
gra-59	86	24	with	with	ADP
gra-59	86	25	controls	control	NOUN
gra-59	86	26	which	which	PRON
gra-59	86	27	is143mg	is143mg	PROPN
gra-59	86	28	/	/	SYM
gra-59	86	29	dl	dl	PROPN
gra-59	86	30	.	.	PROPN
gra-59	87	1	this	this	PRON
gra-59	87	2	was	be	AUX
gra-59	87	3	statistically	statistically	ADV
gra-59	87	4	not	not	PART
gra-59	87	5	signicant	signicant	ADJ
gra-59	87	6	(	(	PUNCT
gra-59	87	7	pvalue0.30	pvalue0.30	PROPN
gra-59	87	8	)	)	PUNCT
gra-59	87	9	.	.	PUNCT
gra-59	88	1	a	a	DET
gra-59	88	2	study	study	NOUN
gra-59	88	3	conducted	conduct	VERB
gra-59	88	4	by	by	ADP
gra-59	88	5	vatten	vatten	ADJ
gra-59	88	6	and	and	CCONJ
gra-59	88	7	foss	foss	PROPN
gra-59	88	8	et	et	PROPN
gra-59	88	9	al6	al6	PROPN
gra-59	88	10	in	in	ADP
gra-59	88	11	1990	1990	NUM
gra-59	88	12	demonstrated	demonstrate	VERB
gra-59	88	13	negative	negative	ADJ
gra-59	88	14	,	,	PUNCT
gra-59	88	15	but	but	CCONJ
gra-59	88	16	notstatistically	notstatistically	ADV
gra-59	88	17	signicant	signicant	ADJ
gra-59	88	18	association	association	NOUN
gra-59	88	19	for	for	ADP
gra-59	88	20	tg	tg	PROPN
gra-59	88	21	with	with	ADP
gra-59	88	22	breast	breast	NOUN
gra-59	88	23	cancer	cancer	NOUN
gra-59	88	24	incidence	incidence	NOUN
gra-59	88	25	,	,	PUNCT
gra-59	88	26	which	which	PRON
gra-59	88	27	showed	show	VERB
gra-59	88	28	further	further	ADJ
gra-59	88	29	insignicance	insignicance	NOUN
gra-59	88	30	after	after	ADP
gra-59	88	31	adjustment	adjustment	NOUN
gra-59	88	32	for	for	ADP
gra-59	88	33	bmi	bmi	NOUN
gra-59	88	34	and	and	CCONJ
gra-59	88	35	serum	serum	NOUN
gra-59	88	36	tc	tc	PROPN
gra-59	88	37	.	.	PUNCT
gra-59	89	1	in	in	ADP
gra-59	89	2	this	this	DET
gra-59	89	3	study	study	NOUN
gra-59	89	4	we	we	PRON
gra-59	89	5	found	find	VERB
gra-59	89	6	mean	mean	VERB
gra-59	89	7	serum	serum	NOUN
gra-59	89	8	cholesterol	cholesterol	NOUN
gra-59	89	9	level	level	NOUN
gra-59	89	10	of	of	ADP
gra-59	89	11	breast	breast	NOUN
gra-59	89	12	cancer	cancer	NOUN
gra-59	89	13	patients	patient	NOUN
gra-59	89	14	was	be	AUX
gra-59	89	15	190.93	190.93	NUM
gra-59	90	1	+	+	NOUN
gra-59	90	2	42.80mg	42.80mg	NUM
gra-59	90	3	/	/	SYM
gra-59	90	4	dl	dl	PROPN
gra-59	90	5	while	while	SCONJ
gra-59	90	6	for	for	ADP
gra-59	90	7	controls	control	NOUN
gra-59	90	8	was	be	AUX
gra-59	90	9	x	x	X
gra-59	90	10	57gjra	57gjra	PROPN
gra-59	90	11	global	global	ADJ
gra-59	90	12	journal	journal	PROPN
gra-59	90	13	for	for	ADP
gra-59	90	14	research	research	NOUN
gra-59	90	15	analysis	analysis	NOUN
gra-59	90	16	volume-8	volume-8	NUM
gra-59	90	17	,	,	PUNCT
gra-59	90	18	issue-9	issue-9	NUM
gra-59	90	19	,	,	PUNCT
gra-59	90	20	september-2019	september-2019	ADJ
gra-59	90	21	•	•	NUM
gra-59	90	22	print	print	NOUN
gra-59	90	23	issn	issn	PROPN
gra-59	90	24	no	no	NOUN
gra-59	90	25	.	.	PROPN
gra-59	90	26	2277	2277	NUM
gra-59	91	1	8160	8160	NUM
gra-59	91	2	•	•	NOUN
gra-59	91	3	doi	doi	NOUN
gra-59	91	4	:	:	PUNCT
gra-59	91	5	10.36106	10.36106	NUM
gra-59	91	6	/	/	SYM
gra-59	91	7	gjra	gjra	NOUN
gra-59	91	8	groups	group	NOUN
gra-59	91	9	no	no	INTJ
gra-59	91	10	.	.	PUNCT
gra-59	91	11	of	of	ADP
gra-59	91	12	cases	case	NOUN
gra-59	91	13	(	(	PUNCT
gra-59	91	14	n	n	CCONJ
gra-59	91	15	)	)	PUNCT
gra-59	91	16	s.	s.	PROPN
gra-59	91	17	hdl	hdl	PROPN
gra-59	91	18	-	-	PUNCT
gra-59	91	19	chol	chol	NOUN
gra-59	91	20	(	(	PUNCT
gra-59	91	21	mg	mg	PROPN
gra-59	91	22	/	/	SYM
gra-59	91	23	dl	dl	PROPN
gra-59	91	24	)	)	PUNCT
gra-59	91	25	t	t	NOUN
gra-59	91	26	-	-	PUNCT
gra-59	91	27	value	value	NOUN
gra-59	91	28	p	p	NOUN
gra-59	91	29	-	-	PUNCT
gra-59	91	30	value	value	NOUN
gra-59	91	31	breast	breast	NOUN
gra-59	91	32	cancer	cancer	NOUN
gra-59	91	33	patients	patient	NOUN
gra-59	91	34	156	156	NUM
gra-59	91	35	39.20	39.20	NUM
gra-59	91	36	±	±	NUM
gra-59	91	37	5.30	5.30	NUM
gra-59	91	38	1.512	1.512	NUM
gra-59	91	39	ns	ns	NUM
gra-59	91	40	control	control	NOUN
gra-59	91	41	156	156	NUM
gra-59	91	42	40.46	40.46	NUM
gra-59	91	43	±	±	NUM
gra-59	91	44	8.96	8.96	NUM
gra-59	91	45	groups	group	NOUN
gra-59	91	46	no	no	INTJ
gra-59	91	47	.	.	PUNCT
gra-59	91	48	of	of	ADP
gra-59	91	49	cases	case	NOUN
gra-59	91	50	(	(	PUNCT
gra-59	91	51	n	n	CCONJ
gra-59	91	52	)	)	PUNCT
gra-59	91	53	s.	s.	PROPN
gra-59	91	54	ldl	ldl	PROPN
gra-59	91	55	(	(	PUNCT
gra-59	91	56	mg	mg	PROPN
gra-59	91	57	/	/	SYM
gra-59	91	58	dl	dl	PROPN
gra-59	91	59	)	)	PUNCT
gra-59	91	60	t	t	NOUN
gra-59	91	61	-	-	PUNCT
gra-59	91	62	value	value	NOUN
gra-59	91	63	p	p	NOUN
gra-59	91	64	-	-	PUNCT
gra-59	91	65	value	value	NOUN
gra-59	91	66	breast	breast	NOUN
gra-59	91	67	cancer	cancer	NOUN
gra-59	91	68	patients	patient	NOUN
gra-59	91	69	156	156	NUM
gra-59	91	70	125.87	125.87	NUM
gra-59	91	71	±	±	NOUN
gra-59	91	72	46.97	46.97	NUM
gra-59	91	73	10.010	10.010	NUM
gra-59	91	74	0.000	0.000	NUM
gra-59	91	75	control	control	NOUN
gra-59	91	76	156	156	NUM
gra-59	91	77	81.54	81.54	NUM
gra-59	91	78	±	±	NUM
gra-59	91	79	29.21	29.21	NUM
gra-59	91	80	groups	group	NOUN
gra-59	91	81	no	no	INTJ
gra-59	91	82	.	.	PUNCT
gra-59	91	83	of	of	ADP
gra-59	91	84	cases	case	NOUN
gra-59	91	85	(	(	PUNCT
gra-59	91	86	n	n	CCONJ
gra-59	91	87	)	)	PUNCT
gra-59	91	88	s.	s.	PROPN
gra-59	91	89	vldl	vldl	PROPN
gra-59	91	90	(	(	PUNCT
gra-59	91	91	mg	mg	PROPN
gra-59	91	92	/	/	SYM
gra-59	91	93	dl	dl	PROPN
gra-59	91	94	)	)	PUNCT
gra-59	91	95	t	t	NOUN
gra-59	91	96	-	-	PUNCT
gra-59	91	97	value	value	NOUN
gra-59	91	98	p	p	NOUN
gra-59	91	99	-	-	PUNCT
gra-59	91	100	value	value	NOUN
gra-59	91	101	breast	breast	NOUN
gra-59	91	102	cancer	cancer	NOUN
gra-59	91	103	patients	patient	NOUN
gra-59	91	104	156	156	NUM
gra-59	91	105	40.55	40.55	NUM
gra-59	91	106	±	±	NUM
gra-59	91	107	10.69	10.69	NUM
gra-59	91	108	2.667	2.667	NUM
gra-59	91	109	0.008	0.008	NUM
gra-59	91	110	control	control	NOUN
gra-59	91	111	156	156	NUM
gra-59	91	112	35.70	35.70	NUM
gra-59	91	113	±	±	NUM
gra-59	91	114	19.94	19.94	NUM
gra-59	91	115	191.25	191.25	NUM
gra-59	91	116	+	+	PROPN
gra-59	91	117	42.31mg	42.31mg	NUM
gra-59	91	118	/	/	SYM
gra-59	91	119	dl	dl	NOUN
gra-59	91	120	this	this	DET
gra-59	91	121	difference	difference	NOUN
gra-59	91	122	was	be	AUX
gra-59	91	123	statistically	statistically	ADV
gra-59	91	124	signicant(pvalue=0.018	signicant(pvalue=0.018	NOUN
gra-59	91	125	)	)	PUNCT
gra-59	91	126	.	.	PUNCT
gra-59	92	1	our	our	PRON
gra-59	92	2	study	study	NOUN
gra-59	92	3	correlated	correlate	VERB
gra-59	92	4	with	with	ADP
gra-59	92	5	the	the	DET
gra-59	92	6	study	study	NOUN
gra-59	92	7	conducted	conduct	VERB
gra-59	92	8	by	by	ADP
gra-59	92	9	dr.seema	dr.seema	X
gra-59	92	10	mishra7	mishra7	ADJ
gra-59	92	11	in	in	ADP
gra-59	92	12	2015	2015	NUM
gra-59	92	13	and	and	CCONJ
gra-59	92	14	she	she	PRON
gra-59	92	15	observed	observe	VERB
gra-59	92	16	that	that	SCONJ
gra-59	92	17	hypocholesterolaemia	hypocholesterolaemia	NOUN
gra-59	92	18	with	with	ADP
gra-59	92	19	decresed	decrese	VERB
gra-59	92	20	hdl	hdl	PROPN
gra-59	92	21	cholesterol	cholesterol	PROPN
gra-59	92	22	and	and	CCONJ
gra-59	92	23	increased	increase	VERB
gra-59	92	24	triglycerides	triglyceride	NOUN
gra-59	92	25	in	in	ADP
gra-59	92	26	patients	patient	NOUN
gra-59	92	27	of	of	ADP
gra-59	92	28	breast	breast	NOUN
gra-59	92	29	cancer	cancer	NOUN
gra-59	92	30	.	.	PUNCT
gra-59	93	1	similarly	similarly	ADV
gra-59	93	2	,	,	PUNCT
gra-59	93	3	according	accord	VERB
gra-59	93	4	to	to	ADP
gra-59	93	5	vinayak	vinayak	PROPN
gra-59	93	6	v	v	PROPN
gra-59	93	7	kshhirsagar	kshhirsagar	PROPN
gra-59	93	8	et	et	PROPN
gra-59	93	9	al5	al5	ADV
gra-59	93	10	in	in	ADP
gra-59	93	11	2016	2016	NUM
gra-59	93	12	,	,	PUNCT
gra-59	93	13	total	total	ADJ
gra-59	93	14	cholesterol	cholesterol	NOUN
gra-59	93	15	level	level	NOUN
gra-59	93	16	in	in	ADP
gra-59	93	17	breast	breast	NOUN
gra-59	93	18	cancer	cancer	NOUN
gra-59	93	19	patients	patient	NOUN
gra-59	93	20	was	be	AUX
gra-59	93	21	165	165	NUM
gra-59	93	22	mg	mg	PROPN
gra-59	93	23	/	/	SYM
gra-59	93	24	dl	dl	PROPN
gra-59	93	25	as	as	SCONJ
gra-59	93	26	compared	compare	VERB
gra-59	93	27	with	with	ADP
gra-59	93	28	control	control	NOUN
gra-59	93	29	group	group	NOUN
gra-59	93	30	which	which	PRON
gra-59	93	31	was	be	AUX
gra-59	93	32	176mg	176mg	PROPN
gra-59	93	33	/	/	SYM
gra-59	93	34	dl	dl	PROPN
gra-59	93	35	.	.	PUNCT
gra-59	94	1	this	this	PRON
gra-59	94	2	was	be	AUX
gra-59	94	3	statically	statically	ADV
gra-59	94	4	signicant	signicant	ADJ
gra-59	94	5	(	(	PUNCT
gra-59	94	6	p	p	NOUN
gra-59	94	7	value	value	NOUN
gra-59	94	8	0.05	0.05	NUM
gra-59	94	9	)	)	PUNCT
gra-59	94	10	.	.	PUNCT
gra-59	95	1	contrast	contrast	NOUN
gra-59	95	2	study	study	NOUN
gra-59	95	3	conducted	conduct	VERB
gra-59	95	4	by	by	ADP
gra-59	95	5	j.k.peela	j.k.peela	PROPN
gra-59	95	6	et	et	PROPN
gra-59	95	7	al4	al4	PROPN
gra-59	95	8	in	in	ADP
gra-59	95	9	2012	2012	NUM
gra-59	95	10	,	,	PUNCT
gra-59	95	11	showed	show	VERB
gra-59	95	12	that	that	SCONJ
gra-59	95	13	serum	serum	NOUN
gra-59	95	14	tc	tc	PROPN
gra-59	95	15	was	be	AUX
gra-59	95	16	signicantly	signicantly	ADV
gra-59	95	17	elevated	elevate	VERB
gra-59	95	18	in	in	ADP
gra-59	95	19	patients	patient	NOUN
gra-59	95	20	with	with	ADP
gra-59	95	21	carcinoma	carcinoma	NOUN
gra-59	95	22	of	of	ADP
gra-59	95	23	breast	breast	NOUN
gra-59	95	24	when	when	SCONJ
gra-59	95	25	compared	compare	VERB
gra-59	95	26	with	with	ADP
gra-59	95	27	control	control	NOUN
gra-59	95	28	group	group	NOUN
gra-59	95	29	and	and	CCONJ
gra-59	95	30	p	p	NOUN
gra-59	95	31	value	value	NOUN
gra-59	95	32	0.0046	0.0046	NUM
gra-59	95	33	.	.	PUNCT
gra-59	96	1	another	another	DET
gra-59	96	2	study	study	NOUN
gra-59	96	3	conducted	conduct	VERB
gra-59	96	4	by	by	ADP
gra-59	96	5	kamal	kamal	PROPN
gra-59	96	6	eldin	eldin	PROPN
gra-59	96	7	a.	a.	PROPN
gra-59	96	8	et	et	PROPN
gra-59	96	9	al8	al8	PROPN
gra-59	96	10	in	in	ADP
gra-59	96	11	2012	2012	NUM
gra-59	96	12	,	,	PUNCT
gra-59	96	13	showed	show	VERB
gra-59	96	14	that	that	SCONJ
gra-59	96	15	the	the	DET
gra-59	96	16	value	value	NOUN
gra-59	96	17	of	of	ADP
gra-59	96	18	t	t	PROPN
gra-59	96	19	-	-	PUNCT
gra-59	96	20	c	c	PROPN
gra-59	96	21	was	be	AUX
gra-59	96	22	signicantly	signicantly	ADV
gra-59	96	23	increased	increase	VERB
gra-59	96	24	in	in	ADP
gra-59	96	25	all	all	DET
gra-59	96	26	four	four	NUM
gra-59	96	27	stages	stage	NOUN
gra-59	96	28	of	of	ADP
gra-59	96	29	breast	breast	NOUN
gra-59	96	30	cancer	cancer	NOUN
gra-59	96	31	compared	compare	VERB
gra-59	96	32	with	with	ADP
gra-59	96	33	that	that	PRON
gra-59	96	34	of	of	ADP
gra-59	96	35	control	control	NOUN
gra-59	96	36	group	group	NOUN
gra-59	96	37	.	.	PUNCT
gra-59	97	1	in	in	ADP
gra-59	97	2	this	this	DET
gra-59	97	3	study	study	NOUN
gra-59	97	4	we	we	PRON
gra-59	97	5	found	find	VERB
gra-59	97	6	mean	mean	PROPN
gra-59	97	7	serum	serum	PROPN
gra-59	97	8	hdl	hdl	PROPN
gra-59	97	9	level	level	NOUN
gra-59	97	10	of	of	ADP
gra-59	97	11	breast	breast	NOUN
gra-59	97	12	cancer	cancer	NOUN
gra-59	97	13	patients	patient	NOUN
gra-59	97	14	was	be	AUX
gra-59	97	15	41.16	41.16	NUM
gra-59	97	16	+	+	NOUN
gra-59	97	17	5.56mg	5.56mg	NUM
gra-59	97	18	/	/	SYM
gra-59	97	19	dl	dl	PROPN
gra-59	97	20	while	while	SCONJ
gra-59	97	21	for	for	ADP
gra-59	97	22	controls	control	NOUN
gra-59	97	23	was	be	AUX
gra-59	97	24	42.91±8.40mg	42.91±8.40mg	PROPN
gra-59	97	25	/	/	SYM
gra-59	97	26	dl	dl	PROPN
gra-59	97	27	.	.	PUNCT
gra-59	98	1	this	this	DET
gra-59	98	2	difference	difference	NOUN
gra-59	98	3	was	be	AUX
gra-59	98	4	statistically	statistically	ADV
gra-59	98	5	signicant(pvalue=0.016	signicant(pvalue=0.016	PROPN
gra-59	98	6	)	)	PUNCT
gra-59	98	7	.	.	PUNCT
gra-59	99	1	vinayakv	vinayakv	PROPN
gra-59	99	2	kshirsagar	kshirsagar	NOUN
gra-59	99	3	et	et	PROPN
gra-59	99	4	al5	al5	ADJ
gra-59	99	5	in	in	ADP
gra-59	99	6	2016,which	2016,which	PROPN
gra-59	99	7	showed	show	VERB
gra-59	99	8	high	high	ADJ
gra-59	99	9	density	density	NOUN
gra-59	99	10	lipoproteins	lipoprotein	NOUN
gra-59	99	11	in	in	ADP
gra-59	99	12	cases	case	NOUN
gra-59	99	13	of	of	ADP
gra-59	99	14	cases	case	NOUN
gra-59	99	15	is	be	AUX
gra-59	99	16	43mg	43mg	ADV
gra-59	99	17	/	/	SYM
gra-59	99	18	dl	dl	PROPN
gra-59	99	19	as	as	SCONJ
gra-59	99	20	compared	compare	VERB
gra-59	99	21	with	with	ADP
gra-59	99	22	the	the	DET
gra-59	99	23	control	control	NOUN
gra-59	99	24	which	which	PRON
gra-59	99	25	is	be	AUX
gra-59	99	26	52mg	52mg	ADJ
gra-59	99	27	/	/	SYM
gra-59	99	28	dl	dl	PROPN
gra-59	99	29	.	.	PUNCT
gra-59	100	1	this	this	PRON
gra-59	100	2	was	be	AUX
gra-59	100	3	stat	stat	NOUN
gra-59	100	4	ist	ist	VERB
gra-59	100	5	ically	ically	ADV
gra-59	100	6	highly	highly	ADV
gra-59	100	7	signicant	signicant	ADJ
gra-59	100	8	(	(	PUNCT
gra-59	100	9	pvalue0.007	pvalue0.007	NOUN
gra-59	100	10	)	)	PUNCT
gra-59	100	11	.	.	PUNCT
gra-59	101	1	according	accord	VERB
gra-59	101	2	to	to	ADP
gra-59	101	3	j.r.peela	j.r.peela	PROPN
gra-59	101	4	et	et	PROPN
gra-59	101	5	al4	al4	PROPN
gra-59	101	6	in	in	ADP
gra-59	101	7	2012	2012	NUM
gra-59	101	8	showed	show	VERB
gra-59	101	9	that	that	SCONJ
gra-59	101	10	serum	serum	NOUN
gra-59	101	11	hdl	hdl	PROPN
gra-59	101	12	-	-	PUNCT
gra-59	101	13	c	c	PROPN
gra-59	101	14	was	be	AUX
gra-59	101	15	signicantly	signicantly	ADV
gra-59	101	16	elevated	elevate	VERB
gra-59	101	17	in	in	ADP
gra-59	101	18	patients	patient	NOUN
gra-59	101	19	with	with	ADP
gra-59	101	20	carcinoma	carcinoma	NOUN
gra-59	101	21	breast	breast	NOUN
gra-59	101	22	when	when	SCONJ
gra-59	101	23	compared	compare	VERB
gra-59	101	24	with	with	ADP
gra-59	101	25	controls(p=0.004	controls(p=0.004	NOUN
gra-59	101	26	)	)	PUNCT
gra-59	101	27	.	.	PUNCT
gra-59	102	1	another	another	DET
gra-59	102	2	scholar	scholar	NOUN
gra-59	102	3	,	,	PUNCT
gra-59	102	4	dr.seema	dr.seema	ADP
gra-59	102	5	mishra7	mishra7	ADJ
gra-59	102	6	in	in	ADP
gra-59	102	7	2015	2015	NUM
gra-59	102	8	observed	observe	VERB
gra-59	102	9	that	that	SCONJ
gra-59	102	10	hypocholesterolaemia	hypocholesterolaemia	NOUN
gra-59	102	11	with	with	ADP
gra-59	102	12	decreased	decrease	VERB
gra-59	102	13	hdlcholesterol	hdlcholesterol	NOUN
gra-59	102	14	in	in	ADP
gra-59	102	15	breast	breast	NOUN
gra-59	102	16	cancer	cancer	NOUN
gra-59	102	17	patients	patient	NOUN
gra-59	102	18	.	.	PUNCT
gra-59	103	1	in	in	ADP
gra-59	103	2	this	this	DET
gra-59	103	3	study	study	NOUN
gra-59	103	4	we	we	PRON
gra-59	103	5	found	find	VERB
gra-59	103	6	mean	mean	VERB
gra-59	103	7	serum	serum	NOUN
gra-59	103	8	ldl	ldl	NOUN
gra-59	103	9	level	level	NOUN
gra-59	103	10	of	of	ADP
gra-59	103	11	breast	breast	NOUN
gra-59	103	12	cancer	cancer	NOUN
gra-59	103	13	patients	patient	NOUN
gra-59	103	14	was	be	AUX
gra-59	103	15	107.46	107.46	NUM
gra-59	103	16	+	+	CCONJ
gra-59	103	17	43.70	43.70	NUM
gra-59	103	18	mg	mg	PROPN
gra-59	103	19	/	/	SYM
gra-59	103	20	dl	dl	PROPN
gra-59	103	21	while	while	SCONJ
gra-59	103	22	for	for	ADP
gra-59	103	23	controls	control	NOUN
gra-59	103	24	was	be	AUX
gra-59	103	25	122.10	122.10	NUM
gra-59	103	26	±47.71mg	±47.71mg	NOUN
gra-59	103	27	/	/	SYM
gra-59	103	28	dl.this	dl.thi	NOUN
gra-59	103	29	difference	difference	NOUN
gra-59	103	30	was	be	AUX
gra-59	103	31	statistically	statistically	ADV
gra-59	103	32	signicant	signicant	ADJ
gra-59	103	33	(	(	PUNCT
gra-59	103	34	pvalue=0.005	pvalue=0.005	NUM
gra-59	103	35	)	)	PUNCT
gra-59	103	36	.	.	PUNCT
gra-59	104	1	according	accord	VERB
gra-59	104	2	to	to	ADP
gra-59	104	3	study	study	NOUN
gra-59	104	4	conducted	conduct	VERB
gra-59	104	5	by	by	ADP
gra-59	104	6	vinayak	vinayak	PROPN
gra-59	104	7	v	v	PROPN
gra-59	104	8	kshirsagar	kshirsagar	NOUN
gra-59	104	9	et	et	NOUN
gra-59	104	10	al5	al5	ADJ
gra-59	104	11	in	in	ADP
gra-59	104	12	2016	2016	NUM
gra-59	104	13	which	which	PRON
gra-59	104	14	showed	show	VERB
gra-59	104	15	that	that	SCONJ
gra-59	104	16	low	low	ADJ
gra-59	104	17	density	density	NOUN
gra-59	104	18	lipoprotein	lipoprotein	ADJ
gra-59	104	19	in	in	ADP
gra-59	104	20	cases	case	NOUN
gra-59	104	21	of	of	ADP
gra-59	104	22	cases	case	NOUN
gra-59	104	23	were	be	AUX
gra-59	104	24	180mg	180mg	PROPN
gra-59	104	25	/	/	SYM
gra-59	104	26	dl	dl	PROPN
gra-59	104	27	ascompared	ascompare	VERB
gra-59	104	28	with	with	ADP
gra-59	104	29	the	the	DET
gra-59	104	30	control	control	NOUN
gra-59	104	31	which	which	PRON
gra-59	104	32	were	be	AUX
gra-59	104	33	198mg	198mg	NOUN
gra-59	104	34	/	/	SYM
gra-59	104	35	dl.this	dl.this	NOUN
gra-59	104	36	was	be	AUX
gra-59	104	37	statistically	statistically	ADV
gra-59	104	38	signicant	signicant	ADJ
gra-59	104	39	(	(	PUNCT
gra-59	104	40	pvalue0.011	pvalue0.011	NOUN
gra-59	104	41	)	)	PUNCT
gra-59	104	42	.	.	PUNCT
gra-59	105	1	another	another	DET
gra-59	105	2	study	study	NOUN
gra-59	105	3	conducted	conduct	VERB
gra-59	105	4	by	by	ADP
gra-59	105	5	j.r.peela	j.r.peela	PROPN
gra-59	105	6	in	in	ADP
gra-59	105	7	et	et	NOUN
gra-59	105	8	al4	al4	PROPN
gra-59	105	9	in	in	ADP
gra-59	105	10	2012	2012	NUM
gra-59	105	11	showed	show	VERB
gra-59	105	12	that	that	SCONJ
gra-59	105	13	levels	level	NOUN
gra-59	105	14	of	of	ADP
gra-59	105	15	ldl	ldl	NOUN
gra-59	105	16	-	-	PUNCT
gra-59	105	17	c	c	PROPN
gra-59	105	18	and	and	CCONJ
gra-59	105	19	tgs	tgs	PROPN
gra-59	105	20	did	do	AUX
gra-59	105	21	not	not	PART
gra-59	105	22	show	show	VERB
gra-59	105	23	any	any	DET
gra-59	105	24	signicant	signicant	ADJ
gra-59	105	25	changes	change	NOUN
gra-59	105	26	between	between	ADP
gra-59	105	27	the	the	DET
gra-59	105	28	cases	case	NOUN
gra-59	105	29	studied	study	VERB
gra-59	105	30	and	and	CCONJ
gra-59	105	31	the	the	DET
gra-59	105	32	controls	control	NOUN
gra-59	105	33	(	(	PUNCT
gra-59	105	34	p=0.42and0.092respectively	p=0.42and0.092respectively	ADV
gra-59	105	35	)	)	PUNCT
gra-59	105	36	.	.	PUNCT
gra-59	106	1	in	in	ADP
gra-59	106	2	this	this	DET
gra-59	106	3	study	study	NOUN
gra-59	106	4	we	we	PRON
gra-59	106	5	found	find	VERB
gra-59	106	6	mean	mean	VERB
gra-59	106	7	serum	serum	NOUN
gra-59	106	8	vldl	vldl	PROPN
gra-59	106	9	level	level	NOUN
gra-59	106	10	of	of	ADP
gra-59	106	11	breast	breast	NOUN
gra-59	106	12	cancer	cancer	NOUN
gra-59	106	13	patients	patient	NOUN
gra-59	106	14	was	be	AUX
gra-59	106	15	44.60	44.60	NUM
gra-59	107	1	+	+	NUM
gra-59	107	2	11.76mg	11.76mg	NUM
gra-59	107	3	/	/	SYM
gra-59	107	4	dl	dl	PROPN
gra-59	107	5	while	while	SCONJ
gra-59	107	6	for	for	ADP
gra-59	107	7	controls	control	NOUN
gra-59	107	8	was	be	AUX
gra-59	107	9	38.29±11.71mg	38.29±11.71mg	NUM
gra-59	107	10	/	/	SYM
gra-59	107	11	dl.this	dl.thi	NOUN
gra-59	107	12	difference	difference	NOUN
gra-59	107	13	was	be	AUX
gra-59	107	14	highly	highly	ADV
gra-59	107	15	statistically	statistically	ADV
gra-59	107	16	signicant	signicant	ADJ
gra-59	107	17	(	(	PUNCT
gra-59	107	18	p	p	NOUN
gra-59	107	19	value=0.000).according	value=0.000).accorde	VERB
gra-59	107	20	to	to	PART
gra-59	107	21	pikul	pikul	VERB
gra-59	107	22	l	l	NOUN
gra-59	107	23	et	et	NOUN
gra-59	107	24	al9,the	al9,the	DET
gra-59	107	25	level	level	NOUN
gra-59	107	26	of	of	ADP
gra-59	107	27	tg	tg	PROPN
gra-59	107	28	,	,	PUNCT
gra-59	107	29	ldl	ldl	NOUN
gra-59	107	30	-	-	PUNCT
gra-59	107	31	c	c	PROPN
gra-59	107	32	,	,	PUNCT
gra-59	108	1	vldl	vldl	NOUN
gra-59	108	2	-	-	PUNCT
gra-59	108	3	c	c	PROPN
gra-59	108	4	(	(	PUNCT
gra-59	108	5	mean	mean	PROPN
gra-59	108	6	±	±	NUM
gra-59	108	7	sd	sd	NOUN
gra-59	108	8	)	)	PUNCT
gra-59	108	9	in	in	ADP
gra-59	108	10	breast	breast	NOUN
gra-59	108	11	cancer	cancer	NOUN
gra-59	108	12	patients	patient	NOUN
gra-59	108	13	were	be	AUX
gra-59	108	14	148.20	148.20	NUM
gra-59	108	15	+	+	NOUN
gra-59	108	16	94.95,143.68	94.95,143.68	NUM
gra-59	108	17	+	+	ADJ
gra-59	108	18	40.01and29.63	40.01and29.63	PROPN
gra-59	108	19	+	+	NOUN
gra-59	108	20	18.9	18.9	NUM
gra-59	108	21	while	while	SCONJ
gra-59	108	22	in	in	ADP
gra-59	108	23	control	control	NOUN
gra-59	108	24	group	group	NOUN
gra-59	108	25	were	be	AUX
gra-59	108	26	217.48	217.48	NUM
gra-59	108	27	+	+	NOUN
gra-59	108	28	47.66	47.66	NUM
gra-59	108	29	and	and	CCONJ
gra-59	108	30	59.45	59.45	NUM
gra-59	108	31	+	+	NUM
gra-59	108	32	15.89	15.89	NUM
gra-59	108	33	respectively.they	respectively.they	PRON
gra-59	108	34	found	find	VERB
gra-59	108	35	thattg	thattg	ADJ
gra-59	108	36	,	,	PUNCT
gra-59	108	37	ldl	ldl	NOUN
gra-59	108	38	-	-	PUNCT
gra-59	108	39	c	c	PROPN
gra-59	108	40	and	and	CCONJ
gra-59	108	41	vldl	vldl	PROPN
gra-59	108	42	-	-	PUNCT
gra-59	108	43	c	c	NOUN
gra-59	108	44	levels	level	NOUN
gra-59	108	45	in	in	ADP
gra-59	108	46	breast	breast	NOUN
gra-59	108	47	cancer	cancer	NOUN
gra-59	108	48	group	group	NOUN
gra-59	108	49	were	be	AUX
gra-59	108	50	signicantly	signicantly	ADV
gra-59	108	51	higher	high	ADJ
gra-59	108	52	than	than	SCONJ
gra-59	108	53	controls	control	NOUN
gra-59	108	54	group(p	group(p	NOUN
gra-59	108	55	<	<	NOUN
gra-59	108	56	0.001	0.001	NUM
gra-59	108	57	)	)	PUNCT
gra-59	108	58	.	.	PUNCT
gra-59	109	1	contrast	contrast	NOUN
gra-59	109	2	study	study	NOUN
gra-59	109	3	conducted	conduct	VERB
gra-59	109	4	by	by	ADP
gra-59	109	5	vinayak	vinayak	PROPN
gra-59	109	6	v	v	PROPN
gra-59	109	7	kshirsagar	kshirsagar	NOUN
gra-59	109	8	et	et	NOUN
gra-59	109	9	al5	al5	VERB
gra-59	109	10	in	in	ADP
gra-59	109	11	2016showed	2016showed	NUM
gra-59	109	12	verylow	verylow	NOUN
gra-59	109	13	densitylipoprotein	densitylipoprotein	ADV
gra-59	109	14	in	in	ADP
gra-59	109	15	case	case	NOUN
gra-59	109	16	of	of	ADP
gra-59	109	17	cases	case	NOUN
gra-59	109	18	was	be	AUX
gra-59	109	19	27mg	27mg	ADJ
gra-59	109	20	/	/	SYM
gra-59	109	21	dl	dl	NOUN
gra-59	109	22	as	as	SCONJ
gra-59	109	23	compared	compare	VERB
gra-59	109	24	with	with	ADP
gra-59	109	25	controls	control	NOUN
gra-59	109	26	which	which	PRON
gra-59	109	27	was	be	AUX
gra-59	109	28	28	28	NUM
gra-59	109	29	mg	mg	PROPN
gra-59	109	30	/	/	SYM
gra-59	109	31	dl	dl	PROPN
gra-59	109	32	.	.	PUNCT
gra-59	110	1	this	this	PRON
gra-59	110	2	was	be	AUX
gra-59	110	3	s	s	PRON
gra-59	110	4	tat	tat	NOUN
gra-59	110	5	is	be	AUX
gra-59	110	6	t	t	NOUN
gra-59	110	7	ical	ical	NOUN
gra-59	110	8	ly	ly	ADP
gra-59	110	9	not	not	PART
gra-59	110	10	signicant(pvalue0.39	signicant(pvalue0.39	NOUN
gra-59	110	11	)	)	PUNCT
gra-59	110	12	.	.	PUNCT
gra-59	111	1	summary	summary	NOUN
gra-59	111	2	&	&	CCONJ
gra-59	111	3	conclusion	conclusion	PROPN
gra-59	111	4	:	:	PUNCT
gra-59	111	5	india	india	PROPN
gra-59	111	6	is	be	AUX
gra-59	111	7	the	the	DET
gra-59	111	8	country	country	NOUN
gra-59	111	9	of	of	ADP
gra-59	111	10	diversity	diversity	NOUN
gra-59	111	11	,	,	PUNCT
gra-59	111	12	which	which	PRON
gra-59	111	13	accounts	account	VERB
gra-59	111	14	for	for	ADP
gra-59	111	15	variation	variation	NOUN
gra-59	111	16	in	in	ADP
gra-59	111	17	the	the	DET
gra-59	111	18	health	health	NOUN
gra-59	111	19	care	care	NOUN
gra-59	111	20	infrastructure.the	infrastructure.the	DET
gra-59	111	21	health	health	NOUN
gra-59	111	22	care	care	NOUN
gra-59	111	23	facility	facility	NOUN
gra-59	111	24	pattern	pattern	NOUN
gra-59	111	25	in	in	ADP
gra-59	111	26	india	india	PROPN
gra-59	111	27	is	be	AUX
gra-59	111	28	heterogeneous	heterogeneous	ADJ
gra-59	111	29	,	,	PUNCT
gra-59	111	30	there	there	PRON
gra-59	111	31	are	be	VERB
gra-59	111	32	some	some	DET
gra-59	111	33	regions	region	NOUN
gra-59	111	34	where	where	SCONJ
gra-59	111	35	basic	basic	ADJ
gra-59	111	36	health	health	NOUN
gra-59	111	37	facility	facility	NOUN
gra-59	111	38	have	have	VERB
gra-59	111	39	yet	yet	ADV
gra-59	111	40	to	to	PART
gra-59	111	41	reach.there	reach.there	PROPN
gra-59	111	42	are	be	AUX
gra-59	111	43	also	also	ADV
gra-59	111	44	some	some	DET
gra-59	111	45	regions	region	NOUN
gra-59	111	46	where	where	SCONJ
gra-59	111	47	people	people	NOUN
gra-59	111	48	are	be	AUX
gra-59	111	49	aware	aware	ADJ
gra-59	111	50	of	of	ADP
gra-59	111	51	breast	breast	NOUN
gra-59	111	52	cancer.carcinoma	cancer.carcinoma	ADJ
gra-59	111	53	breast	breast	NOUN
gra-59	111	54	is	be	AUX
gra-59	111	55	commonest	commonest	NOUN
gra-59	111	56	cancer	cancer	NOUN
gra-59	111	57	in	in	ADP
gra-59	111	58	urban	urban	ADJ
gra-59	111	59	and	and	CCONJ
gra-59	111	60	rural	rural	ADJ
gra-59	111	61	females	female	NOUN
gra-59	111	62	.	.	PUNCT
gra-59	112	1	many	many	ADJ
gra-59	112	2	women	woman	NOUN
gra-59	112	3	donot	donot	PROPN
gra-59	112	4	present	present	VERB
gra-59	112	5	themselves	themselves	PRON
gra-59	112	6	for	for	ADP
gra-59	112	7	check	check	NOUN
gra-59	112	8	-	-	PUNCT
gra-59	112	9	up	up	NOUN
gra-59	112	10	at	at	ADP
gra-59	112	11	hospitals	hospital	NOUN
gra-59	112	12	or	or	CCONJ
gra-59	112	13	medical	medical	ADJ
gra-59	112	14	because	because	SCONJ
gra-59	112	15	of	of	ADP
gra-59	112	16	varied	varied	ADJ
gra-59	112	17	reasons	reason	NOUN
gra-59	112	18	like	like	ADP
gra-59	112	19	illiteracy	illiteracy	NOUN
gra-59	112	20	,	,	PUNCT
gra-59	112	21	monetary	monetary	ADJ
gra-59	112	22	reasons	reason	NOUN
gra-59	112	23	and	and	CCONJ
gra-59	112	24	lack	lack	NOUN
gra-59	112	25	of	of	ADP
gra-59	112	26	knowledge	knowledge	NOUN
gra-59	112	27	.	.	PUNCT
gra-59	113	1	there	there	PRON
gra-59	113	2	are	be	VERB
gra-59	113	3	many	many	ADJ
gra-59	113	4	patients	patient	NOUN
gra-59	113	5	who	who	PRON
gra-59	113	6	present	present	VERB
gra-59	113	7	themselves	themselves	PRON
gra-59	113	8	late	late	ADV
gra-59	113	9	when	when	SCONJ
gra-59	113	10	the	the	DET
gra-59	113	11	disease	disease	NOUN
gra-59	113	12	has	have	AUX
gra-59	113	13	progressed	progress	VERB
gra-59	113	14	to	to	PART
gra-59	113	15	metastaticst	metastaticst	VERB
gra-59	113	16	age	age	NOUN
gra-59	113	17	and	and	CCONJ
gra-59	113	18	at	at	ADP
gra-59	113	19	this	this	DET
gra-59	113	20	stage	stage	NOUN
gra-59	113	21	they	they	PRON
gra-59	113	22	come	come	VERB
gra-59	113	23	to	to	PART
gra-59	113	24	seek	seek	VERB
gra-59	113	25	treatment.lots	treatment.lot	NOUN
gra-59	113	26	of	of	ADP
gra-59	113	27	efforts	effort	NOUN
gra-59	113	28	are	be	AUX
gra-59	113	29	needed	need	VERB
gra-59	113	30	both	both	CCONJ
gra-59	113	31	from	from	ADP
gra-59	113	32	the	the	DET
gra-59	113	33	health	health	NOUN
gra-59	113	34	systems	system	NOUN
gra-59	113	35	as	as	ADV
gra-59	113	36	well	well	ADV
gra-59	113	37	as	as	ADP
gra-59	113	38	from	from	ADP
gra-59	113	39	local	local	ADJ
gra-59	113	40	population	population	NOUN
gra-59	113	41	for	for	ADP
gra-59	113	42	early	early	ADJ
gra-59	113	43	diagnosis	diagnosis	NOUN
gra-59	113	44	of	of	ADP
gra-59	113	45	cancer	cancer	NOUN
gra-59	113	46	breast	breast	NOUN
gra-59	113	47	.	.	PUNCT
gra-59	114	1	conclusion	conclusion	NOUN
gra-59	114	2	of	of	ADP
gra-59	114	3	this	this	DET
gra-59	114	4	study	study	NOUN
gra-59	114	5	were	be	AUX
gra-59	114	6	that	that	PRON
gra-59	114	7	:	:	PUNCT
gra-59	114	8	ÿ	ÿ	PROPN
gra-59	114	9	serum	serum	PROPN
gra-59	114	10	cholesterol	cholesterol	PROPN
gra-59	114	11	,	,	PUNCT
gra-59	114	12	serum	serum	NOUN
gra-59	114	13	ldl	ldl	NOUN
gra-59	114	14	was	be	AUX
gra-59	114	15	signicantly	signicantly	ADV
gra-59	114	16	lower	low	ADJ
gra-59	114	17	in	in	ADP
gra-59	114	18	breast	breast	NOUN
gra-59	114	19	cancer	cancer	NOUN
gra-59	114	20	patients	patient	NOUN
gra-59	114	21	in	in	ADP
gra-59	114	22	compare	compare	NOUN
gra-59	114	23	with	with	ADP
gra-59	114	24	healthy	healthy	ADJ
gra-59	114	25	ÿ	ÿ	PRON
gra-59	114	26	women	woman	NOUN
gra-59	114	27	.	.	PUNCT
gra-59	115	1	ÿ	ÿ	SCONJ
gra-59	115	2	this	this	DET
gra-59	115	3	study	study	NOUN
gra-59	115	4	shows	show	VERB
gra-59	115	5	serum	serum	PROPN
gra-59	115	6	tg	tg	PROPN
gra-59	115	7	,	,	PUNCT
gra-59	115	8	vldl	vldl	PROPN
gra-59	115	9	was	be	AUX
gra-59	115	10	signicantly	signicantly	ADV
gra-59	115	11	higher	high	ADJ
gra-59	115	12	in	in	ADP
gra-59	115	13	breast	breast	NOUN
gra-59	115	14	cancer	cancer	NOUN
gra-59	115	15	patients	patient	NOUN
gra-59	115	16	in	in	ADP
gra-59	115	17	compare	compare	NOUN
gra-59	115	18	with	with	ADP
gra-59	115	19	control	control	NOUN
gra-59	115	20	group	group	NOUN
gra-59	115	21	.	.	PUNCT
gra-59	116	1	ÿ	ÿ	PROPN
gra-59	116	2	the	the	DET
gra-59	116	3	current	current	ADJ
gra-59	116	4	study	study	NOUN
gra-59	116	5	has	have	AUX
gra-59	116	6	shown	show	VERB
gra-59	116	7	a	a	DET
gra-59	116	8	signicant	signicant	ADJ
gra-59	116	9	alteration	alteration	NOUN
gra-59	116	10	in	in	ADP
gra-59	116	11	the	the	DET
gra-59	116	12	serum	serum	NOUN
gra-59	116	13	lipid	lipid	NOUN
gra-59	116	14	prole	prole	PROPN
gra-59	116	15	in	in	ADP
gra-59	116	16	breast	breast	NOUN
gra-59	116	17	cancer	cancer	NOUN
gra-59	116	18	patients	patient	NOUN
gra-59	116	19	.it	.it	PUNCT
gra-59	116	20	is	be	AUX
gra-59	116	21	highly	highly	ADV
gra-59	116	22	recommended	recommend	VERB
gra-59	116	23	that	that	SCONJ
gra-59	116	24	people	people	NOUN
gra-59	116	25	should	should	AUX
gra-59	116	26	reduce	reduce	VERB
gra-59	116	27	weight	weight	NOUN
gra-59	116	28	and	and	CCONJ
gra-59	116	29	control	control	VERB
gra-59	116	30	blood	blood	NOUN
gra-59	116	31	cholesterol	cholesterol	NOUN
gra-59	116	32	levels	level	NOUN
gra-59	116	33	in	in	ADP
gra-59	116	34	order	order	NOUN
gra-59	116	35	to	to	PART
gra-59	116	36	reduce	reduce	VERB
gra-59	116	37	risk	risk	NOUN
gra-59	116	38	of	of	ADP
gra-59	116	39	breast	breast	NOUN
gra-59	116	40	cancer	cancer	NOUN
gra-59	116	41	since	since	SCONJ
gra-59	116	42	there	there	PRON
gra-59	116	43	is	be	VERB
gra-59	116	44	contrasting	contrast	VERB
gra-59	116	45	evidence	evidence	NOUN
gra-59	116	46	on	on	ADP
gra-59	116	47	the	the	DET
gra-59	116	48	correlation	correlation	NOUN
gra-59	116	49	of	of	ADP
gra-59	116	50	lipid	lipid	NOUN
gra-59	116	51	levels	level	NOUN
gra-59	116	52	and	and	CCONJ
gra-59	116	53	breast	breast	NOUN
gra-59	116	54	cancer	cancer	NOUN
gra-59	116	55	,	,	PUNCT
gra-59	116	56	there	there	PRON
gra-59	116	57	is	be	VERB
gra-59	116	58	a	a	DET
gra-59	116	59	need	need	NOUN
gra-59	116	60	for	for	ADP
gra-59	116	61	large	large	ADJ
gra-59	116	62	,	,	PUNCT
gra-59	116	63	multicentric	multicentric	ADJ
gra-59	116	64	and	and	CCONJ
gra-59	116	65	randomized	randomized	ADJ
gra-59	116	66	trials	trial	NOUN
gra-59	116	67	.	.	PUNCT
gra-59	117	1	references	reference	NOUN
gra-59	117	2	:	:	PUNCT
gra-59	118	1	1	1	X
gra-59	118	2	.	.	X
gra-59	118	3	shah	shah	PROPN
gra-59	118	4	f	f	PROPN
gra-59	118	5	d	d	PROPN
gra-59	118	6	,	,	PUNCT
gra-59	118	7	shukla	shukla	PROPN
gra-59	118	8	s	s	PROPN
gra-59	118	9	,	,	PUNCT
gra-59	118	10	shah	shah	PROPN
gra-59	118	11	p	p	NOUN
gra-59	118	12	,	,	PUNCT
gra-59	118	13	patel	patel	PROPN
gra-59	118	14	h	h	NOUN
gra-59	118	15	,	,	PUNCT
gra-59	118	16	patel	patel	PROPN
gra-59	118	17	p.	p.	PROPN
gra-59	118	18	signicance	signicance	PROPN
gra-59	118	19	of	of	ADP
gra-59	118	20	alterations	alteration	NOUN
gra-59	118	21	in	in	ADP
gra-59	118	22	plasma	plasma	NOUN
gra-59	118	23	lipid	lipid	NOUN
gra-59	118	24	prole	prole	PROPN
gra-59	118	25	levels	level	NOUN
gra-59	118	26	in	in	ADP
gra-59	118	27	breast	breast	NOUN
gra-59	118	28	cancer.integr	cancer.integr	NUM
gra-59	118	29	cancerther	cancerther	NOUN
gra-59	118	30	2008;7:33	2008;7:33	NOUN
gra-59	118	31	-	-	PUNCT
gra-59	118	32	41	41	NUM
gra-59	118	33	.	.	NOUN
gra-59	119	1	2	2	X
gra-59	119	2	.	.	X
gra-59	119	3	agarwal	agarwal	PROPN
gra-59	119	4	g	g	PROPN
gra-59	119	5	,	,	PUNCT
gra-59	119	6	pradeepp	pradeepp	NOUN
gra-59	119	7	v	v	NOUN
gra-59	119	8	,	,	PUNCT
gra-59	119	9	aggarwal	aggarwal	NOUN
gra-59	119	10	v	v	NOUN
gra-59	119	11	,	,	PUNCT
gra-59	119	12	yip	yip	PROPN
gra-59	119	13	c	c	PROPN
gra-59	119	14	h	h	PROPN
gra-59	119	15	,	,	PUNCT
gra-59	119	16	cheung	cheung	PROPN
gra-59	119	17	p	p	X
gra-59	119	18	s	s	X
gra-59	119	19	(	(	PUNCT
gra-59	119	20	2007).spectrum	2007).spectrum	NUM
gra-59	119	21	of	of	ADP
gra-59	119	22	breast	breast	NOUN
gra-59	119	23	cancer	cancer	NOUN
gra-59	119	24	in	in	ADP
gra-59	119	25	asian	asian	PROPN
gra-59	119	26	women.world	women.world	PROPN
gra-59	119	27	j	j	PROPN
gra-59	119	28	surg,31,1031	surg,31,1031	PROPN
gra-59	119	29	-	-	PUNCT
gra-59	119	30	40	40	NUM
gra-59	119	31	.	.	PUNCT
gra-59	120	1	3	3	X
gra-59	120	2	.	.	X
gra-59	120	3	raste	raste	NOUN
gra-59	120	4	as	as	ADP
gra-59	120	5	,	,	PUNCT
gra-59	120	6	naik	naik	PROPN
gra-59	120	7	pp	pp	PROPN
gra-59	120	8	.	.	PUNCT
gra-59	121	1	clinical	clinical	ADJ
gra-59	121	2	signicance	signicance	NOUN
gra-59	121	3	of	of	ADP
gra-59	121	4	lipid	lipid	NOUN
gra-59	121	5	prole	prole	PROPN
gra-59	121	6	in	in	ADP
gra-59	121	7	cancer	cancer	NOUN
gra-59	121	8	patients.indian	patients.indian	PROPN
gra-59	121	9	j	j	PROPN
gra-59	121	10	medsci2000;54:435	medsci2000;54:435	VERB
gra-59	121	11	-	-	SYM
gra-59	121	12	41	41	NUM
gra-59	121	13	4	4	NUM
gra-59	121	14	.	.	PUNCT
gra-59	122	1	j.r.peela	j.r.peela	PROPN
gra-59	122	2	,	,	PUNCT
gra-59	122	3	a.m.jarari	a.m.jarari	PROPN
gra-59	122	4	,	,	PUNCT
gra-59	122	5	s.o.elsaiety	s.o.elsaiety	NOUN
gra-59	122	6	,	,	PUNCT
gra-59	122	7	s.elbusai,h.el	s.elbusai,h.el	PROPN
gra-59	122	8	awamy	awamy	ADJ
gra-59	122	9	and	and	CCONJ
gra-59	122	10	shakila	shakila	VERB
gra-59	122	11	srikumar	srikumar	PROPN
gra-59	122	12	:	:	PUNCT
gra-59	122	13	the	the	DET
gra-59	122	14	relationship	relationship	NOUN
gra-59	122	15	between	between	ADP
gra-59	122	16	serum	serum	NOUN
gra-59	122	17	lipids	lipid	NOUN
gra-59	122	18	and	and	CCONJ
gra-59	122	19	breast	breast	NOUN
gra-59	122	20	cancer	cancer	NOUN
gra-59	122	21	in	in	ADP
gra-59	122	22	libya	libya	PROPN
gra-59	122	23	biochem	biochem	PROPN
gra-59	122	24	anal	anal	PROPN
gra-59	122	25	biochem	biochem	PROPN
gra-59	122	26	2012,1:6	2012,1:6	VERB
gra-59	122	27	5	5	NUM
gra-59	122	28	.	.	PUNCT
gra-59	123	1	vinayak	vinayak	PROPN
gra-59	123	2	v	v	NUM
gra-59	123	3	kshirsagar	kshirsagar	NOUN
gra-59	123	4	,	,	PUNCT
gra-59	123	5	dhananjay	dhananjay	PROPN
gra-59	123	6	d	d	PROPN
gra-59	123	7	vaze	vaze	PROPN
gra-59	123	8	,	,	PUNCT
gra-59	123	9	bandu	bandu	PROPN
gra-59	123	10	k	k	PROPN
gra-59	123	11	dhamane	dhamane	PROPN
gra-59	123	12	,	,	PUNCT
gra-59	123	13	seema	seema	PROPN
gra-59	123	14	g	g	PROPN
gra-59	123	15	,	,	PUNCT
gra-59	123	16	prasanna	prasanna	PROPN
gra-59	123	17	a	a	DET
gra-59	123	18	yawalkar	yawalkar	PROPN
gra-59	123	19	,	,	PUNCT
gra-59	123	20	shilpa	shilpa	PROPN
gra-59	123	21	a.pratinidhi	a.pratinidhi	VERB
gra-59	123	22	.comparative	.comparative	ADJ
gra-59	123	23	study	study	NOUN
gra-59	123	24	of	of	ADP
gra-59	123	25	lipid	lipid	NOUN
gra-59	123	26	prole	prole	PROPN
gra-59	123	27	in	in	ADP
gra-59	123	28	patients	patient	NOUN
gra-59	123	29	with	with	ADP
gra-59	123	30	carcinoma	carcinoma	NOUN
gra-59	123	31	breast	breast	NOUN
gra-59	123	32	attending	attend	VERB
gra-59	123	33	a	a	DET
gra-59	123	34	tertiary	tertiary	ADJ
gra-59	123	35	care	care	NOUN
gra-59	123	36	hospital	hospital	NOUN
gra-59	123	37	of	of	ADP
gra-59	123	38	western	western	ADJ
gra-59	123	39	maharashtra	maharashtra	PROPN
gra-59	123	40	:	:	PUNCT
gra-59	123	41	international	international	ADJ
gra-59	123	42	journal	journal	PROPN
gra-59	123	43	of	of	ADP
gra-59	123	44	contemporary	contemporary	PROPN
gra-59	123	45	medical	medical	PROPN
gra-59	123	46	research	research	PROPN
gra-59	123	47	issn	issn	PROPN
gra-59	123	48	(	(	PUNCT
gra-59	123	49	online	online	ADJ
gra-59	123	50	)	)	PUNCT
gra-59	123	51	:	:	PUNCT
gra-59	123	52	2393	2393	NUM
gra-59	123	53	-	-	PUNCT
gra-59	123	54	915x;(print):24547379	915x;(print):24547379	NOUN
gra-59	123	55	.	.	PUNCT
gra-59	124	1	6	6	X
gra-59	124	2	.	.	X
gra-59	124	3	vatten	vatten	PROPN
gra-59	124	4	lj	lj	PROPN
gra-59	124	5	,	,	PUNCT
gra-59	124	6	foss	foss	PROPN
gra-59	124	7	op	op	NOUN
gra-59	124	8	(	(	PUNCT
gra-59	124	9	1990	1990	NUM
gra-59	124	10	)	)	PUNCT
gra-59	124	11	.	.	PUNCT
gra-59	125	1	total	total	ADJ
gra-59	125	2	serum	serum	NOUN
gra-59	125	3	cholesterol	cholesterol	NOUN
gra-59	125	4	and	and	CCONJ
gra-59	125	5	triglycerides	triglyceride	NOUN
gra-59	125	6	and	and	CCONJ
gra-59	125	7	risk	risk	NOUN
gra-59	125	8	of	of	ADP
gra-59	125	9	breast	breast	NOUN
gra-59	125	10	cancer	cancer	NOUN
gra-59	125	11	:	:	PUNCT
gra-59	125	12	a	a	DET
gra-59	125	13	prospective	prospective	ADJ
gra-59	125	14	study	study	NOUN
gra-59	125	15	of	of	ADP
gra-59	125	16	24,329	24,329	NUM
gra-59	125	17	norwegian	norwegian	ADJ
gra-59	125	18	women.cancer	women.cancer	NOUN
gra-59	125	19	res	re	NOUN
gra-59	125	20	50:2341	50:2341	PROPN
gra-59	125	21	-	-	SYM
gra-59	125	22	2346	2346	NUM
gra-59	125	23	.	.	PUNCT
gra-59	126	1	7	7	X
gra-59	126	2	.	.	X
gra-59	126	3	dr	dr	PROPN
gra-59	126	4	.	.	PROPN
gra-59	126	5	seema	seema	PROPN
gra-59	126	6	mishra	mishra	PROPN
gra-59	126	7	:	:	PUNCT
gra-59	126	8	lipid	lipid	PROPN
gra-59	126	9	prole	prole	PROPN
gra-59	126	10	in	in	ADP
gra-59	126	11	breast	breast	NOUN
gra-59	126	12	cancer	cancer	NOUN
gra-59	126	13	patients	patient	NOUN
gra-59	126	14	:	:	PUNCT
gra-59	126	15	international	international	ADJ
gra-59	126	16	journal	journal	NOUN
gra-59	126	17	of	of	ADP
gra-59	126	18	pharmaceutical	pharmaceutical	NOUN
gra-59	126	19	and	and	CCONJ
gra-59	126	20	medical	medical	ADJ
gra-59	126	21	research	research	NOUN
gra-59	126	22	2015	2015	NUM
gra-59	126	23	3(1	3(1	NUM
gra-59	126	24	):	):	PUNCT
gra-59	126	25	29	29	NUM
gra-59	126	26	-	-	SYM
gra-59	126	27	35	35	NUM
gra-59	126	28	.	.	NOUN
gra-59	127	1	8	8	NUM
gra-59	127	2	.	.	X
gra-59	127	3	kamal	kamal	PROPN
gra-59	127	4	el	el	PROPN
gra-59	127	5	din	din	PROPN
gra-59	127	6	a.	a.	PROPN
gra-59	127	7	abdelsalam	abdelsalam	PROPN
gra-59	127	8	,	,	PUNCT
gra-59	127	9	ikhlas	ikhlas	PROPN
gra-59	127	10	k.hassan	k.hassan	PROPN
gra-59	127	11	,	,	PUNCT
gra-59	127	12	and	and	CCONJ
gra-59	127	13	isam	isam	PROPN
gra-59	127	14	a	a	PRON
gra-59	127	15	.	.	PUNCT
gra-59	128	1	sadig	sadig	PROPN
gra-59	128	2	:	:	PUNCT
gra-59	128	3	the	the	DET
gra-59	128	4	role	role	NOUN
gra-59	128	5	of	of	ADP
gra-59	128	6	developing	develop	VERB
gra-59	128	7	breast	breast	NOUN
gra-59	128	8	cancer	cancer	NOUN
gra-59	128	9	in	in	ADP
gra-59	128	10	alteration	alteration	NOUN
gra-59	128	11	of	of	ADP
gra-59	128	12	serum	serum	NOUN
gra-59	128	13	lipid	lipid	NOUN
gra-59	128	14	prole	prole	PROPN
gra-59	128	15	:	:	PUNCT
gra-59	128	16	j	j	PROPN
gra-59	128	17	res	re	NOUN
gra-59	128	18	med	me	VERB
gra-59	128	19	sci.2012jun;17(6):562–565	sci.2012jun;17(6):562–565	PROPN
gra-59	128	20	.	.	PROPN
gra-59	129	1	9	9	X
gra-59	129	2	.	.	X
gra-59	129	3	pikul	pikul	PROPN
gra-59	129	4	l	l	PROPN
gra-59	129	5	,	,	PUNCT
gra-59	129	6	warayupa	warayupa	PROPN
gra-59	129	7	t	t	PROPN
gra-59	129	8	,	,	PUNCT
gra-59	129	9	saowakon	saowakon	PROPN
gra-59	129	10	s	s	PROPN
gra-59	129	11	,	,	PUNCT
gra-59	129	12	adisak	adisak	PROPN
gra-59	129	13	s	s	PROPN
gra-59	129	14	,	,	PUNCT
gra-59	129	15	yuiiana	yuiiana	PROPN
gra-59	129	16	s	s	PART
gra-59	129	17	:	:	PUNCT
gra-59	129	18	comparison	comparison	NOUN
gra-59	129	19	of	of	ADP
gra-59	129	20	serum	serum	NOUN
gra-59	129	21	lipid	lipid	NOUN
gra-59	129	22	proles	prole	NOUN
gra-59	129	23	between	between	ADP
gra-59	129	24	normal	normal	ADJ
gra-59	129	25	controls	control	NOUN
gra-59	129	26	and	and	CCONJ
gra-59	129	27	breast	breast	NOUN
gra-59	129	28	cncer	cncer	NOUN
gra-59	129	29	patients	patient	NOUN
gra-59	129	30	,	,	PUNCT
gra-59	129	31	journal	journal	NOUN
gra-59	129	32	of	of	ADP
gra-59	129	33	laboratory	laboratory	NOUN
gra-59	129	34	physicians	physician	NOUN
gra-59	129	35	2013	2013	NUM
gra-59	129	36	5(1):38	5(1):38	NUM
gra-59	129	37	-	-	PUNCT
gra-59	129	38	41	41	NUM
gra-59	129	39	.	.	PUNCT
gra-59	130	1	58	58	NUM
gra-59	130	2	x	x	NOUN
gra-59	130	3	gjra	gjra	PROPN
gra-59	130	4	global	global	ADJ
gra-59	130	5	journal	journal	PROPN
gra-59	130	6	for	for	ADP
gra-59	130	7	research	research	NOUN
gra-59	130	8	analysis	analysis	NOUN
gra-59	130	9	volume-8	volume-8	NUM
gra-59	130	10	,	,	PUNCT
gra-59	130	11	issue-9	issue-9	NUM
gra-59	130	12	,	,	PUNCT
gra-59	130	13	september-2019	september-2019	ADJ
gra-59	130	14	•	•	NUM
gra-59	130	15	print	print	NOUN
gra-59	130	16	issn	issn	PROPN
gra-59	130	17	no	no	NOUN
gra-59	130	18	.	.	PROPN
gra-59	130	19	2277	2277	NUM
gra-59	130	20	8160	8160	NUM
gra-59	130	21	•	•	NOUN
gra-59	130	22	doi	doi	NOUN
gra-59	130	23	:	:	PUNCT
gra-59	130	24	10.36106	10.36106	NUM
gra-59	130	25	/	/	SYM
gra-59	130	26	gjra	gjra	NOUN